704 is the total number of securities Artal Group S.A. has owned. The longest Artal Group S.A. has owned a single stock is 42 quarters.
Period | Weighting | Quarter | |||||||
---|---|---|---|---|---|---|---|---|---|
Ticker | Name | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
AGEN | AGENUS INC | 42 | 42 | 0.04% | 0.33% | 1.94% | Q2 2013 | Q3 2023 | 42 |
IRWD | IRONWOOD PHARMACEUTICA... | 42 | 42 | 0.02% | 0.08% | 0.27% | Q2 2013 | Q3 2023 | 42 |
ALNY | ALNYLAM PHARMACEUTICAL... | 35 | 2 | 0.01% | 1.70% | 5.06% | Q4 2013 | Q3 2023 | 37 |
LXRX | LEXICON PHARMACEUTICAL... | 34 | 34 | 2.11% | 11.04% | 20.58% | Q2 2015 | Q3 2023 | 34 |
FOLD | AMICUS THERAPEUTICS INC | 30 | 30 | 0.14% | 1.17% | 2.73% | Q2 2016 | Q3 2023 | 30 |
BGNE | BEIGENE LTD | 28 | 28 | 0.20% | 3.56% | 7.37% | Q4 2016 | Q3 2023 | 28 |
BAC | BK OF AMERICA CORP | 13 | 1 | 0.61% | 1.95% | 4.30% | Q2 2013 | Q1 2021 | 28 |
SAGE | SAGE THERAPEUTICS INC | 28 | 28 | 0.12% | 0.67% | 1.87% | Q3 2016 | Q2 2023 | 28 |
AGIO | AGIOS PHARMACEUTICALS INC | 28 | 28 | 0.06% | 0.54% | 1.11% | Q3 2013 | Q2 2020 | 28 |
NKTR | NEKTAR THERAPEUTICS | 26 | 1 | 0.16% | 0.68% | 1.27% | Q2 2013 | Q2 2020 | 27 |
BLUE | BLUEBIRD BIO INC | 27 | 27 | 0.11% | 0.53% | 1.95% | Q3 2013 | Q1 2020 | 27 |
ACIU | AC IMMUNE SA | 26 | 26 | 0.05% | 0.15% | 0.33% | Q3 2016 | Q4 2022 | 26 |
WW | WEIGHT WATCHERS INTL I... | 25 | 25 | 4.20% | 19.28% | 44.73% | Q2 2013 | Q2 2019 | 25 |
BMRN | BIOMARIN PHARMACEUTICA... | 11 | 2 | 0.10% | 0.49% | 1.26% | Q2 2013 | Q1 2021 | 25 |
NTLA | INTELLIA THERAPEUTICS INC | 14 | 1 | 0.02% | 0.33% | 0.88% | Q2 2016 | Q3 2023 | 25 |
MRTX | MIRATI THERAPEUTICS INC | 13 | 1 | 0.03% | 2.06% | 5.57% | Q4 2013 | Q3 2023 | 24 |
BMY | BRISTOL-MYERS SQUIBB CO | 13 | 2 | 0.65% | 1.50% | 7.12% | Q1 2014 | Q4 2021 | 24 |
ATRA | ATARA BIOTHERAPEUTICS INC | 24 | 24 | 0.10% | 0.68% | 1.87% | Q3 2016 | Q2 2022 | 24 |
KRYS | KRYSTAL BIOTECH INC | 24 | 24 | 0.02% | 0.65% | 1.96% | Q3 2017 | Q2 2023 | 24 |
ARRY | ARRAY BIOPHARMA INC | 24 | 24 | 0.14% | 0.58% | 1.99% | Q2 2013 | Q1 2019 | 24 |
DNLI | DENALI THERAPEUTICS INC | 24 | 24 | 0.11% | 0.54% | 1.24% | Q4 2017 | Q3 2023 | 24 |
C | CITIGROUP INC | 7 | 1 | 0.24% | 1.29% | 3.95% | Q2 2013 | Q2 2022 | 23 |
SELB | SELECTA BIOSCIENCES INC | 23 | 23 | 0.02% | 0.27% | 0.42% | Q1 2018 | Q3 2023 | 23 |
GS | GOLDMAN SACHS GROUP INC | 9 | 2 | 0.39% | 2.38% | 8.78% | Q2 2013 | Q3 2020 | 22 |
XLRN | ACCELERON PHARMA INC | 22 | 22 | 0.07% | 2.04% | 5.70% | Q2 2016 | Q3 2021 | 22 |
SRRK | SCHOLAR ROCK HLDG CORP | 22 | 22 | 0.79% | 1.90% | 4.54% | Q2 2018 | Q3 2023 | 22 |
BABA | ALIBABA GROUP HLDG LTD | 11 | 1 | 0.28% | 1.66% | 3.69% | Q3 2014 | Q3 2021 | 22 |
ARGX | ARGENX SE | 21 | 21 | 0.02% | 2.32% | 8.10% | Q3 2017 | Q3 2022 | 21 |
FATE | FATE THERAPEUTICS INC | 21 | 21 | 0.10% | 1.72% | 3.44% | Q1 2018 | Q1 2023 | 21 |
REPL | REPLIMUNE GROUP INC | 21 | 21 | 0.17% | 0.49% | 1.06% | Q3 2018 | Q3 2023 | 21 |
TGTX | TG THERAPEUTICS INC | 20 | 1 | 0.04% | 0.44% | 1.68% | Q2 2017 | Q1 2023 | 21 |
CCXI | CHEMOCENTRYX INC | 19 | 2 | 0.04% | 0.17% | 0.86% | Q2 2013 | Q1 2021 | 21 |
RGNX | REGENXBIO INC | 21 | 21 | 0.03% | 0.16% | 0.40% | Q3 2015 | Q3 2020 | 21 |
BMRN | BIOMARIN PHARMACEUTICA... | 18 | 2 | 0.01% | 0.93% | 2.76% | Q2 2013 | Q2 2023 | 20 |
KURA | KURA ONCOLOGY INC | 17 | 3 | 0.02% | 0.47% | 1.25% | Q3 2017 | Q3 2023 | 20 |
SPRO | SPERO THERAPEUTICS INC | 20 | 20 | 0.02% | 0.16% | 0.31% | Q4 2017 | Q3 2022 | 20 |
GM | GENERAL MTRS CO | 6 | 2 | 0.35% | 1.47% | 4.34% | Q3 2013 | Q2 2021 | 19 |
RUBY | RUBIUS THERAPEUTICS, INC. | 19 | 19 | 0.00% | 1.06% | 2.30% | Q3 2018 | Q1 2023 | 19 |
GOSS | GOSSAMER BIO INC | 19 | 19 | 0.11% | 0.77% | 1.66% | Q1 2019 | Q3 2023 | 19 |
MORF | MORPHIC HLDG INC | 18 | 18 | 0.40% | 2.01% | 4.06% | Q2 2019 | Q3 2023 | 18 |
FOLD | AMICUS THERAPEUTICS INC | 8 | 2 | 0.07% | 0.24% | 0.50% | Q3 2016 | Q3 2023 | 18 |
SLDB | SOLID BIOSCIENCES INC | 11 | 7 | 0.01% | 0.23% | 0.70% | Q1 2018 | Q3 2022 | 18 |
ARAV | ARAVIVE INC | 18 | 18 | 0.05% | 0.22% | 0.71% | Q1 2019 | Q2 2023 | 18 |
CYCN | CYCLERION THERAPEUTICS... | 18 | 18 | 0.00% | 0.19% | 0.66% | Q2 2019 | Q3 2023 | 18 |
HOOK | HOOKIPA PHARMA INC | 18 | 18 | 0.04% | 0.18% | 0.48% | Q2 2019 | Q3 2023 | 18 |
JPM | JPMORGAN CHASE & CO | 13 | 2 | 0.29% | 1.61% | 7.90% | Q2 2013 | Q3 2020 | 17 |
MET | METLIFE INC | 16 | 1 | 0.19% | 1.26% | 2.57% | Q2 2013 | Q4 2017 | 17 |
SWTX | SPRINGWORKS THERAPEUTI... | 17 | 17 | 0.27% | 1.23% | 2.90% | Q3 2019 | Q3 2023 | 17 |
INCY | INCYTE CORP | 17 | 17 | 0.19% | 1.04% | 2.16% | Q1 2014 | Q1 2018 | 17 |
ALBO | ALBIREO PHARMA INC | 17 | 17 | 0.12% | 0.43% | 0.69% | Q4 2017 | Q4 2021 | 17 |
YMAB | Y-MABS THERAPEUTICS INC | 15 | 2 | 0.04% | 0.27% | 0.48% | Q3 2018 | Q4 2022 | 17 |
TCRR | TCR2 THERAPEUTICS INC | 17 | 17 | 0.04% | 0.19% | 0.35% | Q1 2019 | Q1 2023 | 17 |
YI | 111 INC | 17 | 17 | 0.08% | 0.13% | 0.24% | Q3 2018 | Q3 2022 | 17 |
ADRO | ADURO BIOTECH INC | 17 | 17 | 0.02% | 0.06% | 0.16% | Q3 2016 | Q3 2020 | 17 |
MS | MORGAN STANLEY | 3 | 1 | 0.14% | 1.10% | 3.95% | Q1 2014 | Q3 2020 | 16 |
NKTR | NEKTAR THERAPEUTICS | 13 | 1 | 0.13% | 0.31% | 0.99% | Q1 2014 | Q4 2019 | 16 |
PRQR | PROQR THRAPEUTICS N V | 16 | 16 | 0.04% | 0.31% | 0.82% | Q1 2017 | Q4 2020 | 16 |
BBIO | BRIDGEBIO PHARMA INC | 16 | 16 | 0.11% | 0.29% | 0.67% | Q2 2019 | Q1 2023 | 16 |
STML | STEMLINE THERAPEUTICS INC | 12 | 4 | 0.02% | 0.11% | 0.22% | Q4 2013 | Q4 2019 | 16 |
WW | WW INTL INC | 15 | 15 | 2.48% | 8.82% | 22.47% | Q3 2019 | Q1 2023 | 15 |
CELG | CELGENE CORP | 9 | 6 | 0.24% | 1.62% | 3.38% | Q1 2015 | Q1 2019 | 15 |
IGMS | IGM BIOSCIENCES INC | 13 | 2 | 0.14% | 1.53% | 2.38% | Q3 2019 | Q3 2023 | 15 |
WFC | WELLS FARGO CO NEW | 10 | 1 | 0.26% | 1.15% | 2.56% | Q2 2013 | Q4 2018 | 15 |
SDGR | SCHRODINGER INC | 15 | 15 | 0.61% | 1.09% | 2.30% | Q1 2020 | Q3 2023 | 15 |
BDTX | BLACK DIAMOND THERAPEU... | 15 | 15 | 0.12% | 0.60% | 1.82% | Q1 2020 | Q3 2023 | 15 |
IMAB | I MAB | 15 | 15 | 0.05% | 0.54% | 1.34% | Q1 2020 | Q3 2023 | 15 |
FCX | FREEPORT-MCMORAN INC | 7 | 3 | 0.07% | 0.47% | 2.55% | Q2 2013 | Q3 2021 | 15 |
AUPH | AURINIA PHARMACEUTICAL... | 15 | 15 | 0.23% | 0.40% | 0.65% | Q1 2020 | Q3 2023 | 15 |
HARP | HARPOON THERAPEUTICS INC | 15 | 15 | 0.02% | 0.24% | 0.59% | Q4 2019 | Q2 2023 | 15 |
MCRB | SERES THERAPEUTICS INC | 11 | 4 | 0.05% | 0.14% | 0.29% | Q2 2015 | Q2 2021 | 15 |
RXDX | IGNYTA INC | 15 | 15 | 0.07% | 0.13% | 0.29% | Q1 2014 | Q3 2017 | 15 |
CRIS | CURIS INC | 15 | 15 | 0.03% | 0.13% | 0.36% | Q4 2019 | Q2 2023 | 15 |
ORTX | ORCHARD THERAPEUTICS PLC | 15 | 15 | 0.03% | 0.10% | 0.23% | Q2 2019 | Q4 2022 | 15 |
GBIO | GENERATION BIO CO | 14 | 14 | 0.46% | 1.09% | 2.11% | Q2 2020 | Q3 2023 | 14 |
RPTX | REPARE THERAPEUTICS INC | 14 | 14 | 0.23% | 0.40% | 0.58% | Q2 2020 | Q3 2023 | 14 |
AXDX | ACCELERATE DIAGNOSTICS... | 14 | 14 | 0.08% | 0.25% | 0.43% | Q2 2017 | Q3 2020 | 14 |
IMUX | IMMUNIC INC | 14 | 14 | 0.09% | 0.19% | 0.36% | Q4 2019 | Q1 2023 | 14 |
RNA | AVIDITY BIOSCIENCES INC | 14 | 14 | 0.06% | 0.18% | 0.62% | Q2 2020 | Q3 2023 | 14 |
STOK | STOKE THERAPEUTICS INC | 14 | 14 | 0.08% | 0.18% | 0.33% | Q1 2020 | Q2 2023 | 14 |
KLDO | KALEIDO BIOSCIENCES INC | 14 | 14 | 0.00% | 0.15% | 0.56% | Q1 2019 | Q2 2022 | 14 |
AXLA | AXCELLA HEALTH INC | 14 | 14 | 0.04% | 0.08% | 0.15% | Q2 2019 | Q3 2022 | 14 |
KYMR | KYMERA THERAPEUTICS INC | 13 | 13 | 0.17% | 1.21% | 3.18% | Q3 2020 | Q3 2023 | 13 |
BPMC | BLUEPRINT MEDICINES CORP | 11 | 2 | 0.11% | 1.16% | 2.86% | Q4 2017 | Q3 2021 | 13 |
ALVR | ALLOVIR INC | 13 | 13 | 0.48% | 1.13% | 1.92% | Q3 2020 | Q3 2023 | 13 |
ITOS | ITEOS THERAPEUTICS INC | 13 | 13 | 0.16% | 0.49% | 0.79% | Q3 2020 | Q3 2023 | 13 |
MRSN | MERSANA THERAPEUTICS INC | 13 | 13 | 0.20% | 0.45% | 0.72% | Q2 2020 | Q2 2023 | 13 |
FGEN | FIBROGEN INC | 12 | 1 | 0.05% | 0.40% | 0.88% | Q3 2017 | Q4 2020 | 13 |
AAL | AMERICAN AIRLS GROUP INC | 10 | 1 | 0.15% | 0.40% | 0.66% | Q2 2015 | Q4 2020 | 13 |
IOVA | IOVANCE BIOTHERAPEUTIC... | 13 | 13 | 0.10% | 0.37% | 0.95% | Q1 2018 | Q1 2021 | 13 |
WVE | WAVE LIFE SCIENCES LTD | 9 | 1 | 0.05% | 0.36% | 1.17% | Q4 2017 | Q3 2023 | 13 |
TBIO | TRANSLATE BIO INC | 13 | 13 | 0.13% | 0.32% | 0.80% | Q2 2018 | Q2 2021 | 13 |
TSHA | TAYSHA GENE THERAPIES INC | 13 | 13 | 0.03% | 0.32% | 0.62% | Q3 2020 | Q3 2023 | 13 |
ALPN | ALPINE IMMUNE SCIENCES... | 13 | 13 | 0.11% | 0.29% | 0.59% | Q3 2020 | Q3 2023 | 13 |
OVID | OVID THERAPEUTICS INC | 13 | 13 | 0.12% | 0.26% | 0.41% | Q3 2020 | Q3 2023 | 13 |
ADVM | ADVERUM BIOTECHNOLOGIE... | 10 | 3 | 0.03% | 0.25% | 0.58% | Q1 2018 | Q2 2022 | 13 |
DYN | DYNE THERAPEUTICS INC | 13 | 13 | 0.14% | 0.23% | 0.36% | Q3 2020 | Q3 2023 | 13 |
JUNO | JUNO THERAPEUTICS INC | 13 | 13 | 0.07% | 0.18% | 0.44% | Q4 2014 | Q4 2017 | 13 |
LPTX | LEAP THERAPEUTICS INC | 13 | 13 | 0.02% | 0.17% | 0.36% | Q1 2020 | Q1 2023 | 13 |
BTX | BIOTIME INC | 13 | 13 | 0.05% | 0.11% | 0.30% | Q4 2014 | Q4 2017 | 13 |
SEER | SEER INC | 12 | 12 | 0.45% | 2.74% | 7.04% | Q4 2020 | Q3 2023 | 12 |
XBI | SPDR SER TR | 2 | 1 | 0.20% | 2.44% | 16.93% | Q4 2013 | Q2 2023 | 12 |
BIIB | BIOGEN INC | 12 | 12 | 0.75% | 2.15% | 6.08% | Q1 2014 | Q4 2016 | 12 |
MRK | MERCK & CO INC NEW | 11 | 1 | 0.50% | 1.94% | 4.52% | Q2 2013 | Q3 2021 | 12 |
CERE | CEREVEL THERAPEUTICS H... | 12 | 12 | 0.61% | 1.75% | 3.34% | Q4 2020 | Q3 2023 | 12 |
TEVA | TEVA PHARMACEUTICAL IN... | 12 | 12 | 0.47% | 1.00% | 1.73% | Q2 2013 | Q1 2016 | 12 |
RLAY | RELAY THERAPEUTICS INC | 12 | 12 | 0.24% | 0.70% | 1.64% | Q3 2020 | Q2 2023 | 12 |
FHTX | FOGHORN THERAPEUTICS INC | 12 | 12 | 0.37% | 0.67% | 1.25% | Q4 2020 | Q3 2023 | 12 |
MDCO | MEDICINES CO | 12 | 12 | 0.04% | 0.56% | 2.81% | Q4 2016 | Q3 2019 | 12 |
KITE | KITE PHARMA INC | 12 | 12 | 0.18% | 0.48% | 1.12% | Q3 2014 | Q2 2017 | 12 |
KRON | KRONOS BIO INC | 12 | 12 | 0.08% | 0.40% | 0.84% | Q4 2020 | Q3 2023 | 12 |
ALXO | ALX ONCOLOGY HLDGS INC | 12 | 12 | 0.09% | 0.36% | 0.83% | Q3 2020 | Q2 2023 | 12 |
ALNY | ALNYLAM PHARMACEUTICAL... | 4 | 1 | 0.09% | 0.33% | 0.81% | Q3 2015 | Q4 2020 | 12 |
SQZ | SQZ BIOTECHNOLOGIES CO | 12 | 12 | 0.01% | 0.30% | 1.00% | Q4 2020 | Q3 2023 | 12 |
APTX | APTINYX INC | 12 | 12 | 0.10% | 0.25% | 0.58% | Q1 2020 | Q4 2022 | 12 |
NBTX | NANOBIOTIX SA | 12 | 12 | 0.15% | 0.25% | 0.38% | Q4 2020 | Q3 2023 | 12 |
AGIO | AGIOS PHARMACEUTICALS INC | 4 | 2 | 0.05% | 0.24% | 0.56% | Q4 2015 | Q2 2019 | 12 |
TRILLIUM THERAPEUTICS INC | 6 | 6 | 0.00% | 0.22% | 0.66% | Q4 2017 | Q2 2021 | 12 | |
NERV | MINERVA NEUROSCIENCES INC | 7 | 5 | 0.02% | 0.11% | 0.31% | Q3 2016 | Q3 2020 | 12 |
CLLS | CELLECTIS S A | 12 | 12 | 0.04% | 0.09% | 0.19% | Q1 2015 | Q4 2017 | 12 |
BUFF | BLUE BUFFALO PET PRODS... | 11 | 11 | 34.85% | 45.11% | 57.56% | Q3 2015 | Q1 2018 | 11 |
CYTK | CYTOKINETICS INC | 10 | 1 | 0.20% | 1.61% | 2.86% | Q4 2020 | Q3 2023 | 11 |
GE | GENERAL ELECTRIC CO | 11 | 11 | 0.29% | 1.42% | 2.96% | Q2 2013 | Q4 2015 | 11 |
BLU | BELLUS HEALTH INC NEW | 11 | 11 | 0.03% | 1.26% | 3.46% | Q2 2020 | Q4 2022 | 11 |
YUM | YUM! BRANDS INC | 11 | 11 | 0.34% | 1.15% | 2.55% | Q2 2013 | Q4 2015 | 11 |
BABA | ALIBABA GROUP HLDG LTD | 4 | 1 | 0.35% | 0.86% | 3.29% | Q1 2015 | Q4 2020 | 11 |
TPTX | TURNING POINT THERAPEU... | 11 | 11 | 0.32% | 0.58% | 0.92% | Q2 2019 | Q4 2021 | 11 |
IKNA | IKENA ONCOLOGY INC | 11 | 11 | 0.23% | 0.40% | 0.77% | Q1 2021 | Q3 2023 | 11 |
DRNA | DICERNA PHARMACEUTICAL... | 8 | 3 | 0.05% | 0.37% | 0.64% | Q1 2018 | Q3 2021 | 11 |
NG | NOVAGOLD RES INC | 7 | 1 | 0.05% | 0.36% | 0.75% | Q2 2013 | Q4 2021 | 11 |
VOR | VOR BIOPHARMA INC | 11 | 11 | 0.09% | 0.35% | 1.07% | Q1 2021 | Q3 2023 | 11 |
ACHL | ACHILLES THERAPEUTICS PLC | 11 | 11 | 0.07% | 0.27% | 0.66% | Q1 2021 | Q3 2023 | 11 |
FUSN | FUSION PHARMACEUTICALS... | 11 | 11 | 0.08% | 0.17% | 0.44% | Q1 2021 | Q3 2023 | 11 |
ADAG | ADAGENE INC | 11 | 11 | 0.05% | 0.15% | 0.32% | Q1 2021 | Q3 2023 | 11 |
BLUE | BLUEBIRD BIO INC | 3 | 1 | 0.06% | 0.15% | 0.37% | Q4 2014 | Q4 2018 | 11 |
AGLE | AEGLEA BIOTHERAPEUTICS... | 11 | 11 | 0.05% | 0.14% | 0.28% | Q2 2019 | Q4 2021 | 11 |
ORIC | ORIC PHARMACEUTICALS INC | 11 | 11 | 0.04% | 0.11% | 0.19% | Q2 2020 | Q4 2022 | 11 |
MTCR | METACRINE INC | 11 | 11 | 0.02% | 0.08% | 0.32% | Q3 2020 | Q1 2023 | 11 |
CLDX | CELLDEX THERAPEUTICS I... | 11 | 11 | 0.02% | 0.07% | 0.27% | Q2 2015 | Q4 2017 | 11 |
KNTE | KINNATE BIOPHARMA INC | 11 | 11 | 0.01% | 0.06% | 0.11% | Q4 2020 | Q2 2023 | 11 |
CMRX | CHIMERIX INC | 11 | 11 | 0.03% | 0.06% | 0.10% | Q3 2016 | Q1 2019 | 11 |
MEIP | MEI PHARMA INC | 11 | 11 | 0.01% | 0.05% | 0.08% | Q2 2020 | Q4 2022 | 11 |
LVTX | LAVA THERAPEUTICS NV | 11 | 11 | 0.01% | 0.03% | 0.05% | Q1 2021 | Q3 2023 | 11 |
CDTX | CIDARA THERAPEUTICS INC | 11 | 11 | 0.01% | 0.01% | 0.02% | Q2 2020 | Q4 2022 | 11 |
OCX | ONCOCYTE CORPORATION | 11 | 11 | 0.00% | 0.01% | 0.02% | Q1 2016 | Q3 2018 | 11 |
SPY | SPDR S&P 500 ETF TRUST | 8 | 1 | 0.96% | 5.47% | 10.10% | Q2 2013 | Q1 2018 | 10 |
QCOM | QUALCOMM INC | 6 | 1 | 0.47% | 1.02% | 1.57% | Q2 2013 | Q1 2019 | 10 |
Z | ZILLOW GROUP INC | 10 | 10 | 0.12% | 0.86% | 1.88% | Q4 2018 | Q1 2021 | 10 |
GILD | GILEAD SCIENCES INC | 4 | 1 | 0.33% | 0.75% | 1.55% | Q1 2014 | Q4 2017 | 10 |
DCPH | DECIPHERA PHARMACEUTIC... | 10 | 10 | 0.03% | 0.55% | 1.39% | Q3 2019 | Q4 2021 | 10 |
INCY | INCYTE CORP | 4 | 1 | 0.10% | 0.41% | 0.86% | Q4 2015 | Q4 2019 | 10 |
TALS | TALARIS THERAPEUTICS INC | 10 | 10 | 0.09% | 0.41% | 0.86% | Q2 2021 | Q3 2023 | 10 |
XNCR | XENCOR INC | 10 | 10 | 0.03% | 0.39% | 0.73% | Q3 2017 | Q4 2019 | 10 |
VERV | VERVE THERAPEUTICS INC | 10 | 10 | 0.17% | 0.37% | 0.61% | Q2 2021 | Q3 2023 | 10 |
AUTL | AUTOLUS THERAPEUTICS PLC | 10 | 10 | 0.08% | 0.31% | 0.58% | Q2 2018 | Q3 2020 | 10 |
GBT | GLOBAL BLOOD THERAPEUT... | 9 | 1 | 0.04% | 0.17% | 0.68% | Q2 2016 | Q3 2019 | 10 |
SYRS | SYROS PHARMACEUTICALS INC | 10 | 10 | 0.10% | 0.17% | 0.26% | Q1 2020 | Q2 2022 | 10 |
GRTS | GRITSTONE ONCOLOGY INC | 5 | 5 | 0.07% | 0.15% | 0.36% | Q3 2018 | Q4 2022 | 10 |
CRDF | CARDIFF ONCOLOGY INC | 10 | 10 | 0.05% | 0.14% | 0.35% | Q3 2020 | Q4 2022 | 10 |
SANA | SANA BIOTECHNOLOGY INC | 10 | 10 | 0.07% | 0.14% | 0.24% | Q1 2021 | Q2 2023 | 10 |
ZFGN | ZAFGEN INC | 10 | 10 | 0.04% | 0.12% | 0.26% | Q4 2016 | Q1 2019 | 10 |
AKBA | AKEBIA THERAPEUTICS INC | 10 | 10 | 0.06% | 0.11% | 0.22% | Q1 2018 | Q2 2020 | 10 |
CGEM | CULLINAN ONCOLOGY INC | 10 | 10 | 0.05% | 0.11% | 0.17% | Q1 2021 | Q2 2023 | 10 |
APLT | APPLIED THERAPEUTICS INC | 10 | 10 | 0.02% | 0.10% | 0.19% | Q3 2020 | Q4 2022 | 10 |
NK | NANTKWEST INC | 10 | 10 | 0.02% | 0.03% | 0.07% | Q3 2015 | Q4 2017 | 10 |
NVLNF | NOVELION THERAPEUTICS INC | 10 | 10 | 0.01% | 0.03% | 0.06% | Q4 2016 | Q1 2019 | 10 |
MRNA | MODERNA, INC. | 9 | 9 | 0.11% | 2.40% | 4.16% | Q4 2018 | Q4 2020 | 9 |
ERASCA INC | 9 | 9 | 0.40% | 0.97% | 1.51% | Q3 2021 | Q3 2023 | 9 | |
OMEGA THERAPEUTICS INC | 9 | 9 | 0.23% | 0.62% | 0.96% | Q3 2021 | Q3 2023 | 9 | |
GM | GENERAL MTRS CO | 9 | 9 | 0.26% | 0.45% | 0.69% | Q4 2013 | Q4 2015 | 9 |
PRAX | PRAXIS PRECISION MEDIC... | 9 | 9 | 0.12% | 0.43% | 0.89% | Q4 2020 | Q4 2022 | 9 |
3106PS | DELPHI AUTOMOTIVE PLC | 5 | 4 | 0.16% | 0.41% | 0.74% | Q1 2014 | Q3 2016 | 9 |
AMAM | AMBRX BIOPHARMA INC | 9 | 9 | 0.10% | 0.32% | 0.53% | Q2 2021 | Q2 2023 | 9 |
BOLD | AUDENTES THERAPEUTICS INC | 9 | 9 | 0.06% | 0.30% | 0.64% | Q3 2017 | Q3 2019 | 9 |
TCDA | TRICIDA INC | 9 | 9 | 0.06% | 0.30% | 0.58% | Q2 2018 | Q2 2020 | 9 |
XOMA | XOMA CORP DEL | 9 | 9 | 0.15% | 0.25% | 0.48% | Q2 2013 | Q2 2015 | 9 |
ZYME | ZYMEWORKS INC | 9 | 9 | 0.12% | 0.22% | 0.36% | Q4 2020 | Q4 2022 | 9 |
AVXS | AVEXIS INC | 9 | 9 | 0.09% | 0.18% | 0.25% | Q1 2016 | Q1 2018 | 9 |
CFRX | CONTRAFECT CORP | 9 | 9 | 0.01% | 0.12% | 0.25% | Q4 2020 | Q4 2022 | 9 |
OLMA | OLEMA PHARMACEUTICALS INC | 9 | 9 | 0.03% | 0.11% | 0.27% | Q4 2020 | Q4 2022 | 9 |
CARIBOU BIOSCIENCES INC | 9 | 9 | 0.01% | 0.07% | 0.22% | Q3 2021 | Q3 2023 | 9 | |
NVAX | NOVAVAX INC | 9 | 9 | 0.01% | 0.01% | 0.02% | Q3 2016 | Q3 2018 | 9 |
LXRX | LEXICON PHARMACEUTICAL... | 8 | 8 | 12.86% | 16.14% | 19.63% | Q2 2013 | Q1 2015 | 8 |
WMT | WAL-MART STORES INC | 8 | 8 | 0.67% | 1.68% | 5.08% | Q1 2015 | Q4 2016 | 8 |
INTC | INTEL CORP | 5 | 1 | 0.33% | 0.79% | 1.48% | Q4 2013 | Q1 2022 | 8 |
IMGN | IMMUNOGEN INC | 6 | 2 | 0.45% | 0.77% | 1.03% | Q2 2013 | Q3 2023 | 8 |
ACOR | ACORDA THERAPEUTICS INC | 8 | 8 | 0.31% | 0.70% | 1.56% | Q2 2013 | Q1 2015 | 8 |
IBM | INTERNATIONAL BUSINESS... | 8 | 8 | 0.31% | 0.68% | 1.85% | Q2 2016 | Q1 2018 | 8 |
PTGX | PROTAGONIST THERAPEUTI... | 4 | 1 | 0.03% | 0.40% | 1.16% | Q2 2020 | Q2 2023 | 8 |
MET | METLIFE INC | 3 | 1 | 0.10% | 0.40% | 0.94% | Q2 2013 | Q2 2017 | 8 |
BAC | BANK OF AMERICA CORPOR... | 3 | 1 | 0.01% | 0.36% | 0.85% | Q2 2014 | Q1 2023 | 8 |
MS | MORGAN STANLEY | 5 | 1 | 0.09% | 0.27% | 0.58% | Q3 2013 | Q3 2016 | 8 |
ANAB | ANAPTYSBIO INC | 8 | 8 | 0.03% | 0.27% | 0.78% | Q1 2017 | Q4 2018 | 8 |
GLYC | GLYCOMIMETICS INC | 5 | 3 | 0.04% | 0.25% | 0.64% | Q2 2017 | Q3 2023 | 8 |
MARINUS PHARMACEUTICAL... | 8 | 8 | 0.04% | 0.24% | 0.39% | Q4 2020 | Q3 2022 | 8 | |
NEXI | NEXIMMUNE INC | 8 | 8 | 0.02% | 0.21% | 0.41% | Q1 2021 | Q4 2022 | 8 |
MRUS | MERUS N V | 8 | 8 | 0.07% | 0.20% | 0.36% | Q4 2018 | Q3 2020 | 8 |
CERE | CERES INC | 8 | 8 | 0.07% | 0.20% | 0.41% | Q2 2013 | Q1 2015 | 8 |
IMGN | IMMUNOGEN INC | 8 | 8 | 0.16% | 0.20% | 0.26% | Q2 2013 | Q1 2015 | 8 |
PORTAGE FINTECH ACQUIS... | 8 | 8 | 0.08% | 0.16% | 0.23% | Q3 2021 | Q2 2023 | 8 | |
TIL | INSTIL BIO INC | 8 | 8 | 0.02% | 0.15% | 0.21% | Q1 2021 | Q4 2022 | 8 |
RDUS | RADIUS HEALTH INC | 8 | 8 | 0.05% | 0.13% | 0.21% | Q2 2016 | Q1 2018 | 8 |
SGMO | SANGAMO THERAPEUTICS INC | 8 | 8 | 0.04% | 0.13% | 0.18% | Q1 2018 | Q4 2019 | 8 |
AMRN | AMARIN CORP PLC | 7 | 1 | 0.02% | 0.12% | 0.42% | Q2 2013 | Q1 2019 | 8 |
TORC | RESTORBIO INC | 7 | 1 | 0.05% | 0.12% | 0.20% | Q1 2018 | Q2 2020 | 8 |
XILIO THERAPEUTICS INC | 8 | 8 | 0.04% | 0.09% | 0.20% | Q4 2021 | Q3 2023 | 8 | |
JUNO | JUNO THERAPEUTICS INC | 8 | 8 | 0.02% | 0.08% | 0.24% | Q1 2016 | Q4 2017 | 8 |
ME | 23ANDME HOLDING CO | 8 | 8 | 0.03% | 0.08% | 0.12% | Q4 2021 | Q3 2023 | 8 |
MREO | MEREO BIOPHARMA GROUP PLC | 8 | 8 | 0.06% | 0.08% | 0.10% | Q1 2021 | Q4 2022 | 8 |
SGTX | SIGILON THERAPEUTICS INC | 8 | 8 | 0.01% | 0.07% | 0.28% | Q4 2020 | Q3 2022 | 8 |
CDAK | CODIAK BIOSCIENCES INC | 8 | 8 | 0.00% | 0.04% | 0.08% | Q1 2021 | Q4 2022 | 8 |
ADAP | ADAPTIMMUNE THERAPEUTI... | 6 | 2 | 0.02% | 0.04% | 0.07% | Q3 2016 | Q3 2023 | 8 |
YMTX | YUMANITY THERAPEUTICS INC | 8 | 8 | 0.01% | 0.04% | 0.08% | Q4 2020 | Q3 2022 | 8 |
CRVS | CORVUS PHARMACEUTICALS... | 8 | 8 | 0.02% | 0.03% | 0.05% | Q3 2021 | Q2 2023 | 8 |
DMTX | DIMENSION THERAPEUTICS... | 8 | 8 | 0.01% | 0.03% | 0.04% | Q4 2015 | Q3 2017 | 8 |
MINK THERAPEUTICS INC | 8 | 8 | 0.00% | 0.02% | 0.04% | Q4 2021 | Q3 2023 | 8 | |
RIGL | RIGEL PHARMACEUTICALS INC | 8 | 8 | 0.02% | 0.02% | 0.03% | Q1 2020 | Q4 2021 | 8 |
APLS | APELLIS PHARMACEUTICAL... | 5 | 1 | 0.24% | 2.37% | 4.77% | Q1 2019 | Q3 2023 | 7 |
AVTR | AVANTOR INC | 5 | 1 | 0.04% | 2.24% | 5.40% | Q2 2019 | Q3 2022 | 7 |
EPZM | EPIZYME INC | 7 | 7 | 0.29% | 1.02% | 2.14% | Q1 2019 | Q3 2020 | 7 |
MA | MASTERCARD INC | 7 | 7 | 0.37% | 0.79% | 1.61% | Q3 2014 | Q1 2016 | 7 |
VIGIL NEUROSCIENCE INC | 7 | 7 | 0.16% | 0.75% | 1.56% | Q1 2022 | Q3 2023 | 7 | |
ISIS | ISIS PHARMACEUTICALS INC | 7 | 7 | 0.16% | 0.69% | 1.18% | Q1 2014 | Q3 2015 | 7 |
REGN | REGENERON PHARMACEUTICALS | 5 | 2 | 0.21% | 0.64% | 1.47% | Q1 2016 | Q1 2018 | 7 |
SE | SEA LTD | 7 | 7 | 0.20% | 0.62% | 1.56% | Q1 2022 | Q3 2023 | 7 |
BEKE | KE HLDGS INC | 4 | 3 | 0.16% | 0.61% | 1.32% | Q3 2020 | Q3 2023 | 7 |
AMGN | AMGEN INC | 5 | 2 | 0.16% | 0.61% | 1.91% | Q2 2013 | Q4 2017 | 7 |
MU | MICRON TECHNOLOGY INC | 3 | 2 | 0.27% | 0.43% | 0.81% | Q4 2013 | Q4 2018 | 7 |
VRTX | VERTEX PHARMACEUTICALS... | 2 | 1 | 0.20% | 0.41% | 0.81% | Q2 2016 | Q4 2021 | 7 |
TSRO | TESARO INC | 7 | 7 | 0.12% | 0.37% | 0.81% | Q1 2017 | Q3 2018 | 7 |
OTLY | OATLY GROUP AB | 7 | 7 | 0.15% | 0.35% | 0.74% | Q2 2021 | Q4 2022 | 7 |
AIG | AMERICAN INTL GROUP INC | 4 | 1 | 0.01% | 0.35% | 0.89% | Q2 2013 | Q1 2023 | 7 |
MDCO | MEDICINES CO | 7 | 7 | 0.13% | 0.33% | 0.55% | Q2 2017 | Q4 2018 | 7 |
TSRO | TESARO INC | 7 | 7 | 0.03% | 0.26% | 0.57% | Q1 2017 | Q3 2018 | 7 |
NBIX | NEUROCRINE BIOSCIENCES... | 7 | 7 | 0.09% | 0.26% | 0.44% | Q2 2016 | Q4 2017 | 7 |
OMEG | OMEGA ALPHA SPAC | 7 | 7 | 0.13% | 0.24% | 0.40% | Q1 2021 | Q3 2022 | 7 |
AVNR | AVANIR PHARMACEUTICALS... | 7 | 7 | 0.04% | 0.20% | 0.44% | Q2 2013 | Q4 2014 | 7 |
GRPH | GRAPHITE BIO INC | 7 | 7 | 0.10% | 0.20% | 0.44% | Q2 2021 | Q4 2022 | 7 |
LYEL | LYELL IMMUNOPHARMA INC | 7 | 7 | 0.14% | 0.19% | 0.24% | Q2 2021 | Q4 2022 | 7 |
RXRX | RECURSION PHARMACEUTIC... | 7 | 7 | 0.09% | 0.18% | 0.41% | Q2 2021 | Q4 2022 | 7 |
ALDR | ALDER BIOPHARMACEUTICA... | 4 | 3 | 0.06% | 0.16% | 0.40% | Q1 2017 | Q2 2019 | 7 |
EVLO | EVELO BIOSCIENCES INC | 7 | 7 | 0.06% | 0.16% | 0.28% | Q2 2020 | Q4 2021 | 7 |
CLVS | CLOVIS ONCOLOGY INC | 3 | 1 | 0.04% | 0.16% | 0.40% | Q4 2016 | Q1 2020 | 7 |
CLVS | CLOVIS ONCOLOGY INC | 3 | 1 | 0.09% | 0.15% | 0.30% | Q4 2017 | Q2 2020 | 7 |
SRPT | SAREPTA THERAPEUTICS INC | 7 | 7 | 0.04% | 0.13% | 0.36% | Q4 2015 | Q2 2017 | 7 |
NG | NOVAGOLD RES INC | 7 | 7 | 0.08% | 0.12% | 0.20% | Q2 2013 | Q4 2014 | 7 |
CRSP | CRISPR THERAPEUTICS AG | 7 | 7 | 0.01% | 0.11% | 0.21% | Q4 2017 | Q2 2019 | 7 |
IMMP | IMMUTEP LTD | 7 | 7 | 0.07% | 0.09% | 0.12% | Q2 2021 | Q4 2022 | 7 |
ARRY | ARRAY BIOPHARMA INC | 3 | 1 | 0.02% | 0.08% | 0.21% | Q4 2014 | Q4 2017 | 7 |
PARNF | PARNELL PHARMACEUT HLD... | 7 | 7 | 0.02% | 0.07% | 0.11% | Q3 2014 | Q1 2016 | 7 |
MGEN | MIRAGEN THERAPEUTICS INC | 7 | 7 | 0.02% | 0.05% | 0.07% | Q3 2017 | Q1 2019 | 7 |
XENE | XENON PHARMACEUTICALS INC | 7 | 7 | 0.01% | 0.02% | 0.09% | Q1 2017 | Q3 2018 | 7 |
CLCD | COLUCID PHARMACEUTICAL... | 7 | 7 | 0.00% | 0.01% | 0.04% | Q2 2015 | Q4 2016 | 7 |
BNTX | BIONTECH SE | 6 | 6 | 1.74% | 3.18% | 5.50% | Q4 2019 | Q1 2021 | 6 |
AAPL | APPLE INC | 3 | 1 | 0.49% | 1.40% | 2.72% | Q2 2013 | Q3 2020 | 6 |
AUXL | AUXILIUM PHARMACEUTICA... | 6 | 6 | 1.10% | 1.36% | 1.63% | Q2 2013 | Q3 2014 | 6 |
GDS | GDS HLDGS LTD | 4 | 2 | 0.13% | 1.14% | 2.45% | Q2 2020 | Q4 2021 | 6 |
ALXN | ALEXION PHARMACEUTICAL... | 2 | 1 | 0.04% | 0.76% | 1.57% | Q3 2016 | Q2 2020 | 6 |
LLY | LILLY ELI & CO | 5 | 1 | 0.33% | 0.71% | 1.10% | Q2 2013 | Q4 2016 | 6 |
OCN | OCWEN FINL CORP | 6 | 6 | 0.14% | 0.56% | 0.82% | Q2 2013 | Q3 2014 | 6 |
ASND | ASCENDIS PHARMA A S | 6 | 6 | 0.27% | 0.53% | 0.70% | Q1 2019 | Q2 2020 | 6 |
GS | GOLDMAN SACHS GROUP INC | 3 | 1 | 0.21% | 0.46% | 0.64% | Q3 2013 | Q2 2017 | 6 |
FMTX | FORMA THERAPEUTICS HLD... | 6 | 6 | 0.38% | 0.44% | 0.52% | Q4 2020 | Q1 2022 | 6 |
STNE | STONECO LTD | 6 | 6 | 0.31% | 0.43% | 0.62% | Q2 2019 | Q3 2020 | 6 |
AVNR | AVANIR PHARMACEUTICALS... | 6 | 6 | 0.12% | 0.42% | 0.88% | Q2 2013 | Q3 2014 | 6 |
LC | LENDINGCLUB CORP | 6 | 6 | 0.18% | 0.37% | 0.68% | Q4 2014 | Q1 2016 | 6 |
RLGY | REALOGY HLDGS CORP | 3 | 3 | 0.20% | 0.28% | 0.47% | Q3 2013 | Q2 2015 | 6 |
IQ | IQIYI INC | 5 | 1 | 0.12% | 0.23% | 0.32% | Q1 2018 | Q4 2021 | 6 |
ADPT | ADAPTIVE BIOTECHNOLOGI... | 6 | 6 | 0.12% | 0.23% | 0.39% | Q2 2019 | Q3 2020 | 6 |
DSGN | DESIGN THERAPEUTICS INC | 6 | 6 | 0.13% | 0.22% | 0.30% | Q1 2021 | Q2 2022 | 6 |
MDGL | MADRIGAL PHARMACEUTICA... | 6 | 6 | 0.07% | 0.21% | 0.30% | Q1 2018 | Q2 2019 | 6 |
RCKT | ROCKET PHARMACEUTICALS... | 6 | 6 | 0.06% | 0.20% | 0.29% | Q1 2018 | Q2 2019 | 6 |
ALEC | ALECTOR INC | 6 | 6 | 0.13% | 0.17% | 0.26% | Q1 2019 | Q2 2020 | 6 |
HZNP | HORIZON PHARMA PLC | 6 | 6 | 0.11% | 0.16% | 0.26% | Q2 2016 | Q3 2017 | 6 |
KDNY | CHINOOK THERAPEUTICS INC | 5 | 1 | 0.05% | 0.11% | 0.36% | Q4 2020 | Q1 2023 | 6 |
CSLT | CASTLIGHT HEALTH INC | 6 | 6 | 0.08% | 0.11% | 0.15% | Q1 2014 | Q2 2015 | 6 |
RCUS | ARCUS BIOSCIENCES INC | 6 | 6 | 0.06% | 0.10% | 0.15% | Q1 2018 | Q2 2019 | 6 |
VTL | VITAL THERAPIES INC | 6 | 6 | 0.04% | 0.08% | 0.15% | Q1 2017 | Q2 2018 | 6 |
ONCE | SPARK THERAPEUTICS INC | 5 | 1 | 0.05% | 0.08% | 0.22% | Q1 2015 | Q2 2017 | 6 |
XOMA | XOMA CORP DEL | 3 | 3 | 0.01% | 0.08% | 0.15% | Q2 2014 | Q4 2015 | 6 |
MGNX | MACROGENICS INC | 6 | 6 | 0.03% | 0.08% | 0.12% | Q3 2016 | Q4 2017 | 6 |
AVRO | AVROBIO INC | 6 | 6 | 0.01% | 0.07% | 0.14% | Q2 2018 | Q3 2019 | 6 |
MGTA | MAGENTA THERAPEUTICS INC | 5 | 1 | 0.01% | 0.07% | 0.14% | Q2 2018 | Q2 2020 | 6 |
RARE | ULTRAGENYX PHARMACEUTI... | 6 | 6 | 0.04% | 0.06% | 0.08% | Q2 2016 | Q3 2017 | 6 |
SNDX | SYNDAX PHARMACEUTICALS... | 6 | 6 | 0.01% | 0.04% | 0.07% | Q1 2017 | Q2 2018 | 6 |
SENTI BIOSCIENCES INC | 6 | 6 | 0.00% | 0.04% | 0.11% | Q2 2022 | Q3 2023 | 6 | |
SGEN | SEAGEN INC | 5 | 5 | 1.42% | 2.89% | 4.96% | Q3 2021 | Q3 2022 | 5 |
GOOG | GOOGLE INC | 3 | 2 | 0.53% | 1.62% | 5.04% | Q2 2014 | Q3 2015 | 5 |
AUXL | AUXILIUM PHARMACEUTICA... | 5 | 5 | 0.88% | 1.44% | 2.50% | Q4 2013 | Q4 2014 | 5 |
AIG | AMERICAN INTL GROUP INC | 5 | 5 | 1.10% | 1.22% | 1.54% | Q4 2013 | Q4 2014 | 5 |
PCYC | PHARMACYCLICS INC | 5 | 5 | 0.63% | 0.86% | 0.98% | Q4 2013 | Q4 2014 | 5 |
F | FORD MTR CO DEL | 3 | 2 | 0.15% | 0.81% | 1.52% | Q2 2013 | Q2 2021 | 5 |
LNKD | LINKEDIN CORP | 5 | 5 | 0.42% | 0.78% | 1.27% | Q4 2014 | Q4 2015 | 5 |
ITB | ISHARES INC | 5 | 5 | 0.36% | 0.76% | 1.50% | Q3 2013 | Q3 2014 | 5 |
EQRX INC | 5 | 5 | 0.28% | 0.71% | 1.00% | Q4 2021 | Q4 2022 | 5 | |
BRFS | BRF SA | 3 | 2 | 0.37% | 0.65% | 1.08% | Q4 2013 | Q1 2015 | 5 |
NIO | NIO INC | 5 | 5 | 0.12% | 0.64% | 1.32% | Q3 2018 | Q3 2019 | 5 |
EVTCY | EVOTEC AG | 5 | 5 | 0.43% | 0.63% | 0.74% | Q4 2021 | Q4 2022 | 5 |
AMZN | AMAZON COM INC | 2 | 1 | 0.04% | 0.57% | 1.22% | Q2 2014 | Q3 2023 | 5 |
IFRX | INFLARX NV | 5 | 5 | 0.04% | 0.56% | 1.27% | Q1 2018 | Q1 2019 | 5 |
MBBYF | MOBILEYE N V AMSTELVEEN | 4 | 1 | 0.20% | 0.52% | 1.14% | Q3 2014 | Q4 2015 | 5 |
COF | CAPITAL ONE FINL CORP | 3 | 1 | 0.29% | 0.48% | 1.10% | Q2 2013 | Q4 2014 | 5 |
MLCO | MELCO RESORTS AND ENTM... | 3 | 2 | 0.22% | 0.48% | 0.88% | Q4 2018 | Q2 2020 | 5 |
3106PS | DELPHI AUTOMOTIVE PLC | 5 | 5 | 0.23% | 0.43% | 0.70% | Q1 2014 | Q1 2015 | 5 |
NTRA | NATERA INC | 5 | 5 | 0.19% | 0.40% | 0.66% | Q3 2022 | Q3 2023 | 5 |
TCOM | TRIP COM GROUP LTD | 5 | 5 | 0.18% | 0.37% | 0.46% | Q1 2020 | Q1 2021 | 5 |
ZGNX | ZOGENIX INC | 5 | 5 | 0.10% | 0.36% | 0.52% | Q1 2018 | Q1 2019 | 5 |
ZTS | ZOETIS INC | 5 | 5 | 0.19% | 0.31% | 0.39% | Q2 2013 | Q2 2014 | 5 |
PCYC | PHARMACYCLICS INC | 5 | 5 | 0.15% | 0.29% | 0.54% | Q4 2013 | Q4 2014 | 5 |
RLGY | REALOGY HLDGS CORP | 3 | 2 | 0.18% | 0.27% | 0.49% | Q3 2013 | Q4 2014 | 5 |
SYROS PHARMACEUTICALS INC | 5 | 5 | 0.14% | 0.26% | 0.40% | Q3 2022 | Q3 2023 | 5 | |
EXSCIENTIA PLC | 5 | 5 | 0.16% | 0.26% | 0.33% | Q4 2021 | Q4 2022 | 5 | |
DAL | DELTA AIR LINES INC DEL | 2 | 1 | 0.10% | 0.24% | 0.40% | Q3 2014 | Q1 2016 | 5 |
NIO | NIO INC | 5 | 5 | 0.11% | 0.23% | 0.36% | Q4 2018 | Q4 2019 | 5 |
CBAY | CYMABAY THERAPEUTICS INC | 5 | 5 | 0.06% | 0.20% | 0.32% | Q1 2018 | Q1 2019 | 5 |
IMCR | IMMUNOCORE HLDGS PLC | 5 | 5 | 0.15% | 0.18% | 0.25% | Q1 2021 | Q1 2022 | 5 |
MIRION TECHNOLOGIES INC | 5 | 5 | 0.14% | 0.16% | 0.18% | Q4 2021 | Q4 2022 | 5 | |
SRPT | SAREPTA THERAPEUTICS INC | 5 | 5 | 0.09% | 0.15% | 0.24% | Q3 2016 | Q3 2017 | 5 |
SPHS | SOPHIRIS BIO INC | 5 | 5 | 0.09% | 0.12% | 0.15% | Q3 2013 | Q3 2014 | 5 |
TWST | TWIST BIOSCIENCE CORP | 5 | 5 | 0.08% | 0.11% | 0.14% | Q4 2018 | Q4 2019 | 5 |
ELF | E L F BEAUTY INC | 5 | 5 | 0.08% | 0.11% | 0.16% | Q3 2016 | Q3 2017 | 5 |
PRTA | PROTHENA CORP PLC | 4 | 1 | 0.01% | 0.10% | 0.18% | Q4 2019 | Q1 2023 | 5 |
SPNC | SPECTRANETICS CORP | 5 | 5 | 0.03% | 0.08% | 0.14% | Q3 2015 | Q3 2016 | 5 |
AXGT | AXOVANT SCIENCES LTD | 5 | 5 | 0.06% | 0.07% | 0.08% | Q3 2016 | Q3 2017 | 5 |
MRNS | MARINUS PHARMACEUTICAL... | 5 | 5 | 0.02% | 0.06% | 0.13% | Q4 2017 | Q4 2018 | 5 |
BCRX | BIOCRYST PHARMACEUTICA... | 4 | 1 | 0.03% | 0.06% | 0.09% | Q1 2017 | Q1 2023 | 5 |
AKAOQ | ACHAOGEN INC | 5 | 5 | 0.02% | 0.05% | 0.08% | Q4 2016 | Q4 2017 | 5 |
CERE | CERES INC | 5 | 5 | 0.00% | 0.03% | 0.09% | Q2 2015 | Q2 2016 | 5 |
LIFE | ATYR PHARMA INC | 5 | 5 | 0.01% | 0.02% | 0.03% | Q3 2017 | Q3 2018 | 5 |
HIPPO HLDGS INC | 5 | 5 | 0.01% | 0.02% | 0.02% | Q3 2022 | Q3 2023 | 5 | |
SURF | SURFACE ONCOLOGY INC | 5 | 5 | 0.01% | 0.02% | 0.02% | Q4 2020 | Q4 2021 | 5 |
ASTRIA THERAPEUTICS INC | 5 | 5 | 0.01% | 0.01% | 0.01% | Q3 2021 | Q3 2022 | 5 | |
RVMD | REVOLUTION MEDICINES INC | 4 | 4 | 1.33% | 2.25% | 3.00% | Q4 2022 | Q3 2023 | 4 |
FURX | FURIEX PHARMACEUTICALS... | 4 | 4 | 0.98% | 1.55% | 2.52% | Q2 2013 | Q1 2014 | 4 |
MCD | MCDONALDS CORP | 4 | 4 | 0.44% | 1.34% | 2.30% | Q4 2014 | Q3 2015 | 4 |
QURE | UNIQURE NV | 4 | 4 | 0.54% | 1.20% | 2.31% | Q1 2020 | Q4 2020 | 4 |
XLI | SELECT SECTOR SPDR TR | 3 | 1 | 0.86% | 1.07% | 1.50% | Q3 2014 | Q3 2020 | 4 |
ABBV | ABBVIE INC | 3 | 1 | 0.63% | 1.06% | 1.84% | Q2 2017 | Q4 2020 | 4 |
PYPL | PAYPAL HLDGS INC | 3 | 1 | 0.01% | 0.90% | 1.78% | Q4 2019 | Q3 2023 | 4 |
AMZN | AMAZON COM INC | 2 | 1 | 0.29% | 0.88% | 1.83% | Q1 2014 | Q3 2015 | 4 |
HIG | HARTFORD FINL SVCS GRO... | 4 | 4 | 0.49% | 0.78% | 1.49% | Q2 2013 | Q1 2014 | 4 |
CIT | CIT GROUP INC | 2 | 2 | 0.15% | 0.76% | 1.39% | Q2 2013 | Q2 2014 | 4 |
KRTX | KARUNA THERAPEUTICS INC | 3 | 1 | 0.02% | 0.75% | 1.64% | Q4 2019 | Q1 2023 | 4 |
UBER | UBER TECHNOLOGIES INC | 4 | 4 | 0.47% | 0.65% | 0.94% | Q2 2019 | Q1 2020 | 4 |
AMGN | AMGEN INC | 4 | 4 | 0.54% | 0.59% | 0.67% | Q2 2013 | Q1 2014 | 4 |
MJN | MEAD JOHNSON NUTRITION CO | 4 | 4 | 0.30% | 0.50% | 0.60% | Q2 2013 | Q1 2014 | 4 |
SLB | SCHLUMBERGER LTD | 2 | 2 | 0.30% | 0.41% | 0.48% | Q3 2014 | Q1 2021 | 4 |
NBIX | NEUROCRINE BIOSCIENCES... | 2 | 1 | 0.09% | 0.40% | 0.72% | Q4 2016 | Q2 2019 | 4 |
C | CITIGROUP INC | 2 | 2 | 0.20% | 0.38% | 0.57% | Q1 2014 | Q2 2016 | 4 |
DG | DOLLAR GEN CORP NEW | 2 | 1 | 0.16% | 0.34% | 0.50% | Q2 2013 | Q4 2014 | 4 |
A104PS | HILTON WORLDWIDE HLDGS... | 4 | 4 | 0.05% | 0.32% | 0.65% | Q4 2014 | Q3 2015 | 4 |
ALLO | ALLOGENE THERAPEUTICS INC | 4 | 4 | 0.11% | 0.30% | 0.47% | Q4 2018 | Q3 2019 | 4 |
BPMC | BLUEPRINT MEDICINES CORP | 2 | 2 | 0.06% | 0.28% | 0.49% | Q1 2018 | Q1 2020 | 4 |
IONS | IONIS PHARMACEUTICALS INC | 2 | 2 | 0.12% | 0.26% | 0.41% | Q4 2015 | Q2 2017 | 4 |
CFG | CITIZENS FINL GROUP INC | 2 | 1 | 0.01% | 0.25% | 0.84% | Q3 2014 | Q2 2023 | 4 |
TSLA | TESLA MTRS INC | 2 | 1 | 0.04% | 0.23% | 0.35% | Q1 2015 | Q4 2022 | 4 |
ARWR | ARROWHEAD PHARMACEUTIC... | 3 | 1 | 0.01% | 0.20% | 0.73% | Q1 2020 | Q3 2023 | 4 |
SOLID BIOSCIENCES INC | 4 | 4 | 0.10% | 0.19% | 0.27% | Q4 2022 | Q3 2023 | 4 | |
MTG | MGIC INVT CORP WIS | 4 | 4 | 0.15% | 0.17% | 0.18% | Q2 2013 | Q1 2014 | 4 |
CMTA | CLEMENTIA PHARMACEUTIC... | 4 | 4 | 0.04% | 0.17% | 0.37% | Q1 2018 | Q4 2018 | 4 |
DYNS | DYNAMICS SPECIAL PURPO... | 4 | 4 | 0.10% | 0.14% | 0.21% | Q2 2021 | Q1 2022 | 4 |
VKTX | VIKING THERAPEUTICS INC | 3 | 1 | 0.03% | 0.13% | 0.30% | Q2 2019 | Q1 2023 | 4 |
CPAC | CEMENTOS PACASMAYO S A A | 4 | 4 | 0.08% | 0.13% | 0.16% | Q2 2013 | Q1 2014 | 4 |
RDUS | RADIUS HEALTH INC | 3 | 1 | 0.05% | 0.13% | 0.23% | Q2 2016 | Q4 2017 | 4 |
ARPO | AERPIO PHARMACEUTICALS... | 4 | 4 | 0.06% | 0.10% | 0.14% | Q2 2018 | Q1 2019 | 4 |
JNCE | JOUNCE THERAPEUTICS INC | 4 | 4 | 0.03% | 0.07% | 0.15% | Q1 2017 | Q4 2017 | 4 |
SYBX | SYNLOGIC INC | 4 | 4 | 0.05% | 0.07% | 0.08% | Q4 2017 | Q3 2018 | 4 |
CTMX | CYTOMX THERAPEUTICS INC | 2 | 2 | 0.03% | 0.06% | 0.09% | Q4 2018 | Q3 2020 | 4 |
FIXX | HOMOLOGY MEDICINES INC | 4 | 4 | 0.02% | 0.05% | 0.08% | Q1 2018 | Q4 2018 | 4 |
AGEN | AGENUS INC | 4 | 4 | 0.04% | 0.05% | 0.07% | Q1 2016 | Q4 2016 | 4 |
HIPPO HLDGS INC | 4 | 4 | 0.03% | 0.05% | 0.06% | Q3 2021 | Q2 2022 | 4 | |
XLE | SELECT SECTOR SPDR TR | 4 | 4 | 0.04% | 0.04% | 0.05% | Q2 2020 | Q1 2021 | 4 |
CHMA | CHIASMA INC | 4 | 4 | 0.02% | 0.03% | 0.04% | Q3 2020 | Q2 2021 | 4 |
KINETA INC | 4 | 4 | 0.00% | 0.01% | 0.01% | Q4 2022 | Q3 2023 | 4 | |
NVDA | NVIDIA CORP | 3 | 3 | 1.40% | 2.42% | 3.08% | Q1 2019 | Q3 2019 | 3 |
IWM | ISHARES TR | 3 | 3 | 0.96% | 1.81% | 3.22% | Q2 2014 | Q4 2014 | 3 |
IBB | ISHARES TR | 1 | 1 | 0.64% | 1.42% | 2.57% | Q1 2014 | Q2 2018 | 3 |
PEP | PEPSICO INC | 3 | 3 | 0.78% | 1.16% | 1.81% | Q3 2013 | Q1 2014 | 3 |
GOOGL | GOOGLE INC | 3 | 3 | 0.36% | 0.99% | 1.82% | Q4 2013 | Q2 2014 | 3 |
MRTX | MIRATI THERAPEUTICS INC | 2 | 1 | 0.28% | 0.95% | 1.31% | Q4 2022 | Q3 2023 | 3 |
BGNE | BEIGENE LTD | 2 | 1 | 0.29% | 0.85% | 1.23% | Q4 2018 | Q4 2022 | 3 |
VENTYX BIOSCIENCES INC | 3 | 3 | 0.42% | 0.70% | 1.07% | Q1 2023 | Q3 2023 | 3 | |
VMC | VULCAN MATLS CO | 2 | 1 | 0.52% | 0.68% | 0.89% | Q4 2013 | Q3 2014 | 3 |
CL | COLGATE PALMOLIVE CO | 3 | 3 | 0.58% | 0.62% | 0.69% | Q4 2013 | Q2 2014 | 3 |
FXI | ISHARES TR | 2 | 1 | 0.26% | 0.59% | 0.77% | Q1 2014 | Q4 2016 | 3 |
GERN | GERON CORP | 3 | 3 | 0.51% | 0.59% | 0.72% | Q1 2023 | Q3 2023 | 3 |
SLN | SILENCE THERAPEUTICS PLC | 3 | 3 | 0.19% | 0.51% | 1.05% | Q1 2023 | Q3 2023 | 3 |
VRDN | VIRIDIAN THERAPEUTICS INC | 3 | 3 | 0.33% | 0.49% | 0.76% | Q1 2023 | Q3 2023 | 3 |
EWW | ISHARES INC | 2 | 1 | 0.31% | 0.46% | 0.72% | Q2 2013 | Q1 2014 | 3 |
ROIVANT SCIENCES LTD | 3 | 3 | 0.26% | 0.42% | 0.51% | Q1 2023 | Q3 2023 | 3 | |
TECH | BIO-TECHNE CORP | 3 | 3 | 0.36% | 0.42% | 0.48% | Q2 2020 | Q4 2020 | 3 |
UAL | UNITED CONTL HLDGS INC | 2 | 1 | 0.33% | 0.41% | 0.54% | Q4 2013 | Q3 2014 | 3 |
CELG | CELGENE CORP | 2 | 1 | 0.22% | 0.40% | 0.70% | Q4 2015 | Q4 2016 | 3 |
M | MACYS INC | 3 | 3 | 0.19% | 0.39% | 0.78% | Q3 2013 | Q1 2014 | 3 |
ATH | ATHENE HLDG LTD | 3 | 3 | 0.17% | 0.37% | 0.50% | Q4 2016 | Q2 2017 | 3 |
ESRX | EXPRESS SCRIPTS HLDG CO | 3 | 3 | 0.25% | 0.35% | 0.40% | Q2 2013 | Q4 2013 | 3 |
ALXN | ALEXION PHARMACEUTICAL... | 3 | 3 | 0.21% | 0.34% | 0.54% | Q4 2016 | Q2 2017 | 3 |
MRNA | MODERNA INC | 3 | 3 | 0.30% | 0.33% | 0.38% | Q2 2019 | Q4 2019 | 3 |
DHR | DANAHER CORPORATION | 2 | 1 | 0.24% | 0.33% | 0.39% | Q3 2020 | Q2 2023 | 3 |
HTHT | HUAZHU GROUP LTD | 2 | 1 | 0.17% | 0.31% | 0.51% | Q1 2019 | Q2 2020 | 3 |
BRFS | BRF SA | 1 | 1 | 0.23% | 0.30% | 0.34% | Q2 2013 | Q1 2015 | 3 |
XLRN | ACCELERON PHARMA INC | 2 | 1 | 0.10% | 0.27% | 0.38% | Q2 2018 | Q1 2019 | 3 |
OCN | OCWEN FINL CORP | 1 | 1 | 0.15% | 0.25% | 0.45% | Q2 2013 | Q2 2014 | 3 |
TEX | TEREX CORP NEW | 2 | 1 | 0.08% | 0.24% | 0.33% | Q3 2013 | Q2 2014 | 3 |
SAGE | SAGE THERAPEUTICS INC | 2 | 1 | 0.06% | 0.23% | 0.35% | Q2 2016 | Q1 2022 | 3 |
JMEI | JUMEI INTL HLDG LTD | 3 | 3 | 0.08% | 0.23% | 0.49% | Q2 2015 | Q4 2015 | 3 |
TSM | TAIWAN SEMICONDUCTOR M... | 3 | 3 | 0.13% | 0.23% | 0.38% | Q1 2023 | Q3 2023 | 3 |
REAL | THE REALREAL INC | 3 | 3 | 0.02% | 0.23% | 0.51% | Q2 2019 | Q4 2019 | 3 |
ZTO | ZTO EXPRESS CAYMAN INC | 3 | 3 | 0.12% | 0.22% | 0.28% | Q4 2016 | Q2 2017 | 3 |
JPM | JPMORGAN CHASE & CO | 2 | 1 | 0.17% | 0.22% | 0.25% | Q2 2013 | Q1 2016 | 3 |
RL | RALPH LAUREN CORP | 3 | 3 | 0.15% | 0.20% | 0.29% | Q1 2014 | Q3 2014 | 3 |
BRKR | BRUKER CORP | 3 | 3 | 0.17% | 0.19% | 0.21% | Q2 2020 | Q4 2020 | 3 |
ACOR | ACORDA THERAPEUTICS INC | 3 | 3 | 0.12% | 0.19% | 0.23% | Q3 2014 | Q1 2015 | 3 |
KORS | MICHAEL KORS HLDGS LTD | 2 | 1 | 0.13% | 0.19% | 0.24% | Q2 2013 | Q3 2014 | 3 |
MTOR | MERITOR INC | 3 | 3 | 0.13% | 0.19% | 0.24% | Q3 2013 | Q1 2014 | 3 |
CRNX | CRINETICS PHARMACEUTIC... | 3 | 3 | 0.15% | 0.19% | 0.22% | Q3 2018 | Q1 2019 | 3 |
IONS | IONIS PHARMACEUTICALS INC | 2 | 1 | 0.12% | 0.16% | 0.21% | Q4 2015 | Q4 2016 | 3 |
GDX | MARKET VECTORS ETF TR | 3 | 3 | 0.15% | 0.16% | 0.16% | Q2 2013 | Q4 2013 | 3 |
NEOG | NEOGEN CORP | 3 | 3 | 0.08% | 0.16% | 0.20% | Q1 2014 | Q3 2014 | 3 |
PLRX | PLIANT THERAPEUTICS INC | 3 | 3 | 0.00% | 0.14% | 0.40% | Q1 2023 | Q3 2023 | 3 |
V | VISA INC | 2 | 1 | 0.06% | 0.13% | 0.26% | Q4 2015 | Q3 2023 | 3 |
JD | JD COM INC | 3 | 3 | 0.11% | 0.13% | 0.14% | Q2 2016 | Q4 2016 | 3 |
LJPC | LA JOLLA PHARMACEUTICA... | 3 | 3 | 0.10% | 0.12% | 0.16% | Q1 2018 | Q3 2018 | 3 |
PASG | PASSAGE BIO INC | 3 | 3 | 0.01% | 0.12% | 0.18% | Q1 2020 | Q3 2020 | 3 |
PRVL | PREVAIL THERAPEUTICS INC | 3 | 3 | 0.08% | 0.11% | 0.15% | Q1 2020 | Q3 2020 | 3 |
SGEN | SEATTLE GENETICS INC. | 2 | 1 | 0.09% | 0.11% | 0.14% | Q4 2013 | Q3 2017 | 3 |
HZNP | HORIZON PHARMA PLC | 3 | 3 | 0.10% | 0.11% | 0.11% | Q2 2017 | Q4 2017 | 3 |
LC | LENDINGCLUB CORP | 3 | 3 | 0.07% | 0.11% | 0.16% | Q2 2015 | Q4 2015 | 3 |
ADCT | ADC THERAPEUTICS SA | 3 | 3 | 0.06% | 0.11% | 0.18% | Q2 2020 | Q4 2020 | 3 |
CRWD | CROWDSTRIKE HLDGS INC | 2 | 1 | 0.01% | 0.10% | 0.28% | Q2 2019 | Q3 2023 | 3 |
VSAR | VERSARTIS INC | 3 | 3 | 0.02% | 0.09% | 0.14% | Q1 2017 | Q3 2017 | 3 |
AMBI | AMBIT BIOSCIENCES CORP | 3 | 3 | 0.07% | 0.08% | 0.09% | Q4 2013 | Q2 2014 | 3 |
PTLA | PORTOLA PHARMACEUTICAL... | 2 | 1 | 0.04% | 0.07% | 0.11% | Q4 2017 | Q1 2020 | 3 |
LOXO | LOXO ONCOLOGY INC | 3 | 3 | 0.04% | 0.06% | 0.07% | Q3 2016 | Q1 2017 | 3 |
AIMT | AIMMUNE THERAPEUTICS INC | 3 | 3 | 0.04% | 0.05% | 0.09% | Q4 2016 | Q2 2017 | 3 |
ACHN | ACHILLION PHARMACEUTIC... | 3 | 3 | 0.03% | 0.05% | 0.08% | Q3 2017 | Q1 2018 | 3 |
IGMS | IGM BIOSCIENCES INC | 3 | 3 | 0.05% | 0.05% | 0.05% | Q2 2022 | Q4 2022 | 3 |
CEMP | CEMPRA INC | 3 | 3 | 0.01% | 0.05% | 0.10% | Q2 2016 | Q4 2016 | 3 |
VSTM | VERASTEM INC | 3 | 3 | 0.02% | 0.04% | 0.06% | Q2 2017 | Q4 2017 | 3 |
CALA | CALITHERA BIOSCIENCES INC | 3 | 3 | 0.01% | 0.04% | 0.05% | Q2 2017 | Q4 2017 | 3 |
CRBP | CORBUS PHARMACEUTICALS... | 3 | 3 | 0.02% | 0.03% | 0.04% | Q2 2017 | Q4 2017 | 3 |
TOCA | TOCAGEN INC | 3 | 3 | 0.02% | 0.02% | 0.02% | Q4 2017 | Q2 2018 | 3 |
BEAM | BEAM THERAPEUTICS INC | 3 | 3 | 0.01% | 0.01% | 0.02% | Q1 2023 | Q3 2023 | 3 |
CEREW | CEREVEL THERAPEUTICS H... | 3 | 3 | 0.01% | 0.01% | 0.02% | Q4 2020 | Q2 2021 | 3 |
CAVA GROUP INC | 2 | 2 | 40.62% | 41.33% | 42.04% | Q2 2023 | Q3 2023 | 2 | |
GWW | GRAINGER W W INC | 2 | 2 | 1.12% | 1.48% | 1.85% | Q3 2014 | Q4 2014 | 2 |
GOOG | GOOGLE INC | 2 | 2 | 0.46% | 1.37% | 2.28% | Q4 2014 | Q1 2015 | 2 |
ACELYRIN INC | 2 | 2 | 1.08% | 1.13% | 1.18% | Q2 2023 | Q3 2023 | 2 | |
AXP | AMERICAN EXPRESS CO | 2 | 2 | 0.74% | 1.12% | 1.50% | Q2 2015 | Q3 2015 | 2 |
ISEE | IVERIC BIO INC | 2 | 2 | 0.57% | 0.88% | 1.20% | Q3 2022 | Q4 2022 | 2 |
CMG | CHIPOTLE MEXICAN GRILL... | 2 | 2 | 0.63% | 0.80% | 0.96% | Q3 2016 | Q4 2016 | 2 |
NVDA | NVIDIA CORP | 1 | 1 | 0.65% | 0.66% | 0.66% | Q1 2014 | Q2 2019 | 2 |
RPRX | ROYALTY PHARMA PLC | 2 | 2 | 0.26% | 0.64% | 1.02% | Q2 2020 | Q3 2020 | 2 |
TVTX | TRAVERE THERAPEUTICS INC | 2 | 2 | 0.59% | 0.64% | 0.68% | Q4 2022 | Q1 2023 | 2 |
AAL | AMERICAN AIRLS GROUP INC | 1 | 1 | 0.55% | 0.62% | 0.69% | Q2 2015 | Q2 2020 | 2 |
GOOGL | ALPHABET INC | 2 | 2 | 0.58% | 0.61% | 0.64% | Q2 2016 | Q3 2016 | 2 |
AGN | ALLERGAN PLC | 2 | 2 | 0.49% | 0.60% | 0.71% | Q3 2017 | Q4 2017 | 2 |
ENDP | ENDO INTL PLC | 2 | 2 | 0.34% | 0.56% | 0.77% | Q3 2015 | Q4 2015 | 2 |
CAR | AVIS BUDGET GROUP | 2 | 2 | 0.47% | 0.53% | 0.58% | Q1 2021 | Q2 2021 | 2 |
CCI | CROWN CASTLE INTL CORP... | 2 | 2 | 0.35% | 0.52% | 0.69% | Q2 2015 | Q3 2015 | 2 |
INTC | INTEL CORP | 1 | 1 | 0.08% | 0.49% | 0.90% | Q1 2017 | Q1 2021 | 2 |
VNET | 21VIANET GROUP INC | 2 | 2 | 0.39% | 0.49% | 0.59% | Q1 2020 | Q2 2020 | 2 |
PRNB | PRINCIPIA BIOPHARMA INC | 2 | 2 | 0.34% | 0.48% | 0.63% | Q1 2020 | Q2 2020 | 2 |
HON | HONEYWELL INTL INC | 2 | 2 | 0.38% | 0.44% | 0.51% | Q2 2014 | Q3 2014 | 2 |
CTSH | COGNIZANT TECHNOLOGY S... | 2 | 2 | 0.40% | 0.44% | 0.49% | Q2 2014 | Q3 2014 | 2 |
BHVN | BIOHAVEN PHARMACTL HLD... | 1 | 1 | 0.03% | 0.41% | 0.79% | Q3 2017 | Q2 2021 | 2 |
FURX | FURIEX PHARMACEUTICALS... | 2 | 2 | 0.32% | 0.37% | 0.43% | Q1 2014 | Q2 2014 | 2 |
ETNB | 89BIO INC | 2 | 2 | 0.28% | 0.37% | 0.45% | Q4 2022 | Q1 2023 | 2 |
UAL | UNITED CONTL HLDGS INC | 1 | 1 | 0.25% | 0.36% | 0.47% | Q3 2013 | Q1 2015 | 2 |
WYNN | WYNN RESORTS LTD | 2 | 2 | 0.33% | 0.35% | 0.37% | Q3 2018 | Q4 2018 | 2 |
PFE | PFIZER INC | 2 | 2 | 0.34% | 0.35% | 0.36% | Q3 2016 | Q4 2016 | 2 |
YUM | YUM BRANDS INC | 2 | 2 | 0.27% | 0.34% | 0.41% | Q3 2015 | Q4 2015 | 2 |
AFFX | AFFYMETRIX INC | 2 | 2 | 0.24% | 0.32% | 0.40% | Q2 2013 | Q3 2013 | 2 |
VICI | VICI PPTYS INC | 2 | 2 | 0.28% | 0.32% | 0.36% | Q4 2018 | Q1 2019 | 2 |
EPZM | EPIZYME INC | 2 | 2 | 0.16% | 0.31% | 0.45% | Q1 2020 | Q2 2020 | 2 |
HAL | HALLIBURTON CO | 1 | 1 | 0.28% | 0.30% | 0.32% | Q1 2014 | Q4 2014 | 2 |
OIH | MARKET VECTORS ETF TR | 1 | 1 | 0.13% | 0.29% | 0.46% | Q1 2014 | Q4 2014 | 2 |
ARQL | ARQULE INC | 2 | 2 | 0.24% | 0.28% | 0.31% | Q2 2019 | Q3 2019 | 2 |
FB | FACEBOOK INC | 1 | 1 | 0.16% | 0.28% | 0.39% | Q2 2013 | Q1 2017 | 2 |
MAS | MASCO CORP | 2 | 2 | 0.17% | 0.27% | 0.37% | Q3 2013 | Q4 2013 | 2 |
ARMK | ARAMARK | 1 | 1 | 0.21% | 0.27% | 0.33% | Q2 2014 | Q4 2014 | 2 |
AXDX | ACCELERATE DIAGNOSTICS... | 2 | 2 | 0.24% | 0.27% | 0.30% | Q2 2018 | Q3 2018 | 2 |
OXY | OCCIDENTAL PETE CORP DEL | 1 | 1 | 0.09% | 0.26% | 0.42% | Q4 2014 | Q3 2020 | 2 |
HOG | HARLEY DAVIDSON INC | 1 | 1 | 0.21% | 0.25% | 0.28% | Q3 2014 | Q1 2015 | 2 |
TER | TERADYNE INC | 2 | 2 | 0.22% | 0.24% | 0.26% | Q2 2017 | Q3 2017 | 2 |
F | FORD MTR CO DEL | 2 | 2 | 0.15% | 0.24% | 0.33% | Q2 2013 | Q3 2013 | 2 |
MDLZ | MONDELEZ INTL INC | 2 | 2 | 0.20% | 0.23% | 0.25% | Q3 2013 | Q4 2013 | 2 |
DAWN | DAY ONE BIOPHARMACEUTI... | 2 | 2 | 0.18% | 0.22% | 0.26% | Q2 2023 | Q3 2023 | 2 |
EEM | ISHARES TR | 1 | 1 | 0.18% | 0.21% | 0.24% | Q2 2013 | Q3 2015 | 2 |
TWX | TIME WARNER INC | 2 | 2 | 0.18% | 0.21% | 0.23% | Q3 2015 | Q4 2015 | 2 |
LGFA | LIONS GATE ENTMNT CORP | 2 | 2 | 0.18% | 0.20% | 0.21% | Q3 2019 | Q4 2019 | 2 |
ADAGIO THERAPEUTICS INC | 2 | 2 | 0.18% | 0.18% | 0.19% | Q1 2022 | Q2 2022 | 2 | |
KITE | KITE PHARMA INC | 2 | 2 | 0.17% | 0.18% | 0.19% | Q3 2015 | Q4 2015 | 2 |
USFD | US FOODS HLDG CORP | 2 | 2 | 0.10% | 0.18% | 0.25% | Q2 2016 | Q3 2016 | 2 |
CMCSK | COMCAST CORP NEW | 2 | 2 | 0.13% | 0.17% | 0.22% | Q1 2014 | Q2 2014 | 2 |
VALE | VALE S A | 1 | 1 | 0.09% | 0.17% | 0.24% | Q4 2017 | Q4 2018 | 2 |
DLO | DLOCAL LTD | 1 | 1 | 0.02% | 0.17% | 0.32% | Q2 2021 | Q4 2021 | 2 |
FLDM | FLUIDIGM CORP DEL | 2 | 2 | 0.12% | 0.15% | 0.17% | Q2 2013 | Q3 2013 | 2 |
MTOR | MERITOR INC | 2 | 2 | 0.06% | 0.14% | 0.22% | Q2 2013 | Q3 2013 | 2 |
QCOM | QUALCOMM INC | 1 | 1 | 0.11% | 0.13% | 0.15% | Q3 2013 | Q4 2015 | 2 |
DOYU | DOUYU INTERNATIONAL HL... | 2 | 2 | 0.13% | 0.13% | 0.13% | Q3 2019 | Q4 2019 | 2 |
GBT | GLOBAL BLOOD THERAPEUT... | 2 | 2 | 0.12% | 0.13% | 0.13% | Q2 2017 | Q3 2017 | 2 |
BZ | KANZHUN LIMITED | 2 | 2 | 0.10% | 0.12% | 0.14% | Q2 2023 | Q3 2023 | 2 |
PGEM | PLY GEM HLDGS INC | 2 | 2 | 0.10% | 0.11% | 0.12% | Q2 2013 | Q3 2013 | 2 |
LEG | LEGGETT & PLATT INC | 2 | 2 | 0.10% | 0.10% | 0.11% | Q3 2013 | Q4 2013 | 2 |
ZNTL | ZENTALIS PHARMACEUTICA... | 2 | 2 | 0.07% | 0.10% | 0.12% | Q2 2020 | Q3 2020 | 2 |
BTX | BIOTIME INC | 2 | 2 | 0.09% | 0.09% | 0.09% | Q1 2015 | Q2 2015 | 2 |
SGEN | SEATTLE GENETICS INC. | 2 | 2 | 0.07% | 0.09% | 0.10% | Q1 2017 | Q2 2017 | 2 |
VXRT | VAXART INC | 2 | 2 | 0.05% | 0.09% | 0.12% | Q2 2020 | Q3 2020 | 2 |
DVAX | DYNAVAX TECHNOLOGIES CORP | 2 | 2 | 0.06% | 0.07% | 0.08% | Q1 2018 | Q2 2018 | 2 |
IDRA | IDERA PHARMACEUTICALS INC | 2 | 2 | 0.06% | 0.07% | 0.08% | Q1 2018 | Q2 2018 | 2 |
SFXEQ | SFX ENTMT INC | 2 | 2 | 0.05% | 0.06% | 0.08% | Q2 2014 | Q3 2014 | 2 |
VIAC | VIACOMCBS INC | 2 | 2 | 0.05% | 0.06% | 0.07% | Q1 2021 | Q2 2021 | 2 |
AMYLYX PHARMACEUTICALS... | 2 | 2 | 0.04% | 0.06% | 0.08% | Q1 2022 | Q2 2022 | 2 | |
FPRX | FIVE PRIME THERAPEUTIC... | 2 | 2 | 0.04% | 0.06% | 0.08% | Q2 2017 | Q3 2017 | 2 |
CCXI | CHEMOCENTRYX INC | 2 | 2 | 0.02% | 0.06% | 0.10% | Q3 2014 | Q4 2014 | 2 |
DVAX | DYNAVAX TECHNOLOGIES CORP | 2 | 2 | 0.06% | 0.06% | 0.06% | Q3 2017 | Q4 2017 | 2 |
CSLT | CASTLIGHT HEALTH INC | 2 | 2 | 0.05% | 0.05% | 0.06% | Q2 2014 | Q3 2014 | 2 |
MSFT | MICROSOFT CORP | 2 | 2 | 0.03% | 0.05% | 0.07% | Q2 2023 | Q3 2023 | 2 |
SQ | SQUARE INC | 1 | 1 | 0.03% | 0.05% | 0.08% | Q3 2019 | Q3 2023 | 2 |
SMT | SMART TECHNOLOGIES INC | 2 | 2 | 0.05% | 0.05% | 0.05% | Q2 2013 | Q3 2013 | 2 |
IDYA | IDEAYA BIOSCIENCES INC | 2 | 2 | 0.00% | 0.05% | 0.10% | Q2 2020 | Q3 2020 | 2 |
AEGR | AEGERION PHARMACEUTICA... | 2 | 2 | 0.03% | 0.04% | 0.06% | Q2 2016 | Q3 2016 | 2 |
UBX | UNITY BIOTECHNOLOGY INC | 2 | 2 | 0.02% | 0.04% | 0.06% | Q2 2018 | Q3 2018 | 2 |
AMYT | AMRYT PHARMA PLC | 2 | 2 | 0.04% | 0.04% | 0.04% | Q3 2021 | Q4 2021 | 2 |
OPHT | OPHTHOTECH CORP | 2 | 2 | 0.03% | 0.04% | 0.05% | Q2 2016 | Q3 2016 | 2 |
PANW | PALO ALTO NETWORKS INC | 1 | 1 | 0.02% | 0.04% | 0.06% | Q1 2016 | Q4 2022 | 2 |
ACET | ADICET BIO INC | 2 | 2 | 0.04% | 0.04% | 0.04% | Q3 2020 | Q4 2020 | 2 |
BIOD | BIODEL INC | 2 | 2 | 0.03% | 0.03% | 0.04% | Q2 2013 | Q3 2013 | 2 |
UTHR | UNITED THERAPEUTICS CO... | 2 | 2 | 0.02% | 0.03% | 0.04% | Q1 2023 | Q2 2023 | 2 |
DDOG | DATADOG INC | 2 | 2 | 0.02% | 0.03% | 0.04% | Q2 2023 | Q3 2023 | 2 |
NLNK | NEWLINK GENETICS CORP | 2 | 2 | 0.02% | 0.03% | 0.04% | Q3 2017 | Q4 2017 | 2 |
AMD | ADVANCED MICRO DEVICES... | 2 | 2 | 0.02% | 0.02% | 0.03% | Q2 2023 | Q3 2023 | 2 |
GOOGL | ALPHABET INC | 2 | 2 | 0.02% | 0.02% | 0.03% | Q2 2023 | Q3 2023 | 2 |
CYCLERION THERAPEUTICS... | 2 | 2 | 0.02% | 0.02% | 0.02% | Q2 2023 | Q3 2023 | 2 | |
EDIT | EDITAS MEDICINE INC | 2 | 2 | 0.01% | 0.02% | 0.02% | Q4 2017 | Q1 2018 | 2 |
NEURODERM LTD | 2 | 2 | 0.01% | 0.01% | 0.02% | Q1 2017 | Q2 2017 | 2 | |
PCOR | PROCORE TECHNOLOGIES INC | 2 | 2 | 0.01% | 0.01% | 0.01% | Q2 2023 | Q3 2023 | 2 |
QQQ | INVESCO QQQ TR | 1 | 1 | 13.88% | 13.88% | 13.88% | Q3 2020 | Q3 2020 | 1 |
EWZ | ISHARES INC | 1 | 1 | 2.76% | 2.76% | 2.76% | Q2 2013 | Q2 2013 | 1 |
NEUMORA THERAPEUTICS INC | 1 | 1 | 1.70% | 1.70% | 1.70% | Q3 2023 | Q3 2023 | 1 | |
LABU | DIREXION SHS ETF TR | 1 | 1 | 1.44% | 1.44% | 1.44% | Q2 2022 | Q2 2022 | 1 |
BANK AMER CORP | 1 | 1 | 1.26% | 1.26% | 1.26% | Q4 2015 | Q4 2015 | 1 | |
MSFT | MICROSOFT CORP | 1 | 1 | 1.20% | 1.20% | 1.20% | Q2 2017 | Q2 2017 | 1 |
APPLE INC | 1 | 1 | 1.19% | 1.19% | 1.19% | Q4 2015 | Q4 2015 | 1 | |
MA | MASTERCARD INC | 1 | 1 | 1.02% | 1.02% | 1.02% | Q1 2020 | Q1 2020 | 1 |
DAL | DELTA AIR LINES INC DEL | 1 | 1 | 0.98% | 0.98% | 0.98% | Q2 2020 | Q2 2020 | 1 |
XOM | EXXON MOBIL CORP | 1 | 1 | 0.93% | 0.93% | 0.93% | Q1 2018 | Q1 2018 | 1 |
EWJ | ISHARES INC | 1 | 1 | 0.88% | 0.88% | 0.88% | Q2 2013 | Q2 2013 | 1 |
AA | ALCOA CORP | 1 | 1 | 0.86% | 0.86% | 0.86% | Q1 2021 | Q1 2021 | 1 |
ONXX | ONYX PHARMACEUTICALS INC | 1 | 1 | 0.82% | 0.82% | 0.82% | Q2 2013 | Q2 2013 | 1 |
ONXX | ONYX PHARMACEUTICALS INC | 1 | 1 | 0.82% | 0.82% | 0.82% | Q2 2013 | Q2 2013 | 1 |
RXDX | PROMETHEUS BIOSCIENCES... | 1 | 1 | 0.78% | 0.78% | 0.78% | Q1 2023 | Q1 2023 | 1 |
AER | AERCAP HOLDINGS NV | 1 | 1 | 0.74% | 0.74% | 0.74% | Q2 2015 | Q2 2015 | 1 |
CVX | CHEVRON CORP NEW | 1 | 1 | 0.71% | 0.71% | 0.71% | Q1 2018 | Q1 2018 | 1 |
YELP | YELP INC | 1 | 1 | 0.66% | 0.66% | 0.66% | Q1 2015 | Q1 2015 | 1 |
MOONLAKE IMMUNOTHERAPE... | 1 | 1 | 0.63% | 0.63% | 0.63% | Q2 2023 | Q2 2023 | 1 | |
AAPL | APPLE INC | 1 | 1 | 0.62% | 0.62% | 0.62% | Q2 2013 | Q2 2013 | 1 |
BEKE | KE HLDGS INC | 1 | 1 | 0.62% | 0.62% | 0.62% | Q4 2022 | Q4 2022 | 1 |
AVGO | BROADCOM INC | 1 | 1 | 0.61% | 0.61% | 0.61% | Q1 2021 | Q1 2021 | 1 |
SGEN | SEAGEN INC | 1 | 1 | 0.58% | 0.58% | 0.58% | Q3 2022 | Q3 2022 | 1 |
INSM | INSMED INC | 1 | 1 | 0.56% | 0.56% | 0.56% | Q4 2022 | Q4 2022 | 1 |
V | VISA INC | 1 | 1 | 0.55% | 0.55% | 0.55% | Q3 2014 | Q3 2014 | 1 |
RAYZEBIO INC | 1 | 1 | 0.53% | 0.53% | 0.53% | Q3 2023 | Q3 2023 | 1 | |
2SEVENTY BIO INC | 1 | 1 | 0.46% | 0.46% | 0.46% | Q1 2023 | Q1 2023 | 1 | |
MJN | MEAD JOHNSON NUTRITION CO | 1 | 1 | 0.45% | 0.45% | 0.45% | Q1 2014 | Q1 2014 | 1 |
CHNG | CHANGE HEALTHCARE INC | 1 | 1 | 0.44% | 0.44% | 0.44% | Q2 2019 | Q2 2019 | 1 |
LNKD | LINKEDIN CORP | 1 | 1 | 0.40% | 0.40% | 0.40% | Q4 2014 | Q4 2014 | 1 |
DLPH | DELPHI TECHNOLOGIES PLC | 1 | 1 | 0.40% | 0.40% | 0.40% | Q3 2019 | Q3 2019 | 1 |
FIS | FIDELITY NATL INFORMAT... | 1 | 1 | 0.40% | 0.40% | 0.40% | Q3 2019 | Q3 2019 | 1 |
RETA | REATA PHARMACEUTICALS INC | 1 | 1 | 0.40% | 0.40% | 0.40% | Q4 2019 | Q4 2019 | 1 |
FRX | FOREST LABS INC | 1 | 1 | 0.39% | 0.39% | 0.39% | Q2 2013 | Q2 2013 | 1 |
BIOHAVEN LTD | 1 | 1 | 0.39% | 0.39% | 0.39% | Q4 2022 | Q4 2022 | 1 | |
BLK | BLACKROCK INC | 1 | 1 | 0.38% | 0.38% | 0.38% | Q3 2017 | Q3 2017 | 1 |
ISEE | IVERIC BIO INC | 1 | 1 | 0.38% | 0.38% | 0.38% | Q3 2022 | Q3 2022 | 1 |
CAT | CATERPILLAR INC DEL | 1 | 1 | 0.37% | 0.37% | 0.37% | Q1 2018 | Q1 2018 | 1 |
REGN | REGENERON PHARMACEUTICALS | 1 | 1 | 0.36% | 0.36% | 0.36% | Q2 2016 | Q2 2016 | 1 |
ESV | ENSCO PLC | 1 | 1 | 0.35% | 0.35% | 0.35% | Q3 2013 | Q3 2013 | 1 |
SAGIMET BIOSCIENCES INC | 1 | 1 | 0.35% | 0.35% | 0.35% | Q3 2023 | Q3 2023 | 1 | |
CPNG | COUPANG INC | 1 | 1 | 0.35% | 0.35% | 0.35% | Q1 2021 | Q1 2021 | 1 |
EMR | EMERSON ELEC CO | 1 | 1 | 0.34% | 0.34% | 0.34% | Q2 2013 | Q2 2013 | 1 |
OIH | VANECK VECTORS ETF TR | 1 | 1 | 0.34% | 0.34% | 0.34% | Q1 2017 | Q1 2017 | 1 |
VRX | VALEANT PHARMACEUTICAL... | 1 | 1 | 0.34% | 0.34% | 0.34% | Q2 2013 | Q2 2013 | 1 |
BANK AMER CORP | 1 | 1 | 0.32% | 0.32% | 0.32% | Q4 2015 | Q4 2015 | 1 | |
EWW | ISHARES INC | 1 | 1 | 0.31% | 0.31% | 0.31% | Q2 2013 | Q2 2013 | 1 |
Q | QUINTILES TRANSNATIO H... | 1 | 1 | 0.30% | 0.30% | 0.30% | Q2 2013 | Q2 2013 | 1 |
TWX | TIME WARNER INC | 1 | 1 | 0.30% | 0.30% | 0.30% | Q4 2014 | Q4 2014 | 1 |
ARCO | ARCOS DORADOS HOLDINGS... | 1 | 1 | 0.29% | 0.29% | 0.29% | Q2 2013 | Q2 2013 | 1 |
RL | RALPH LAUREN CORP | 1 | 1 | 0.29% | 0.29% | 0.29% | Q1 2014 | Q1 2014 | 1 |
LFST | LIFESTANCE HEALTH GROU... | 1 | 1 | 0.28% | 0.28% | 0.28% | Q2 2021 | Q2 2021 | 1 |
HOG | HARLEY DAVIDSON INC | 1 | 1 | 0.28% | 0.28% | 0.28% | Q1 2015 | Q1 2015 | 1 |
BNTX | BIONTECH SE | 1 | 1 | 0.28% | 0.28% | 0.28% | Q2 2020 | Q2 2020 | 1 |
KWEB | KRANESHARES TR | 1 | 1 | 0.27% | 0.27% | 0.27% | Q1 2021 | Q1 2021 | 1 |
BHF | BRIGHTHOUSE FINL INC | 1 | 1 | 0.26% | 0.26% | 0.26% | Q4 2017 | Q4 2017 | 1 |
CCI | CROWN CASTLE INTL CORP | 1 | 1 | 0.26% | 0.26% | 0.26% | Q4 2013 | Q4 2013 | 1 |
AMERICAN EXPRESS CO | 1 | 1 | 0.26% | 0.26% | 0.26% | Q4 2015 | Q4 2015 | 1 | |
FGEN | FIBROGEN INC | 1 | 1 | 0.26% | 0.26% | 0.26% | Q4 2018 | Q4 2018 | 1 |
FOXA | TWENTY FIRST CENTY FOX... | 1 | 1 | 0.25% | 0.25% | 0.25% | Q3 2014 | Q3 2014 | 1 |
FSL | FREESCALE SEMICONDUCTO... | 1 | 1 | 0.25% | 0.25% | 0.25% | Q3 2014 | Q3 2014 | 1 |
AGL | AGILON HEALTH INC | 1 | 1 | 0.25% | 0.25% | 0.25% | Q2 2021 | Q2 2021 | 1 |
AURA BIOSCIENCES INC | 1 | 1 | 0.24% | 0.24% | 0.24% | Q4 2022 | Q4 2022 | 1 | |
ANNX | ANNEXON INC | 1 | 1 | 0.23% | 0.23% | 0.23% | Q1 2023 | Q1 2023 | 1 |
IMMU | IMMUNOMEDICS INC | 1 | 1 | 0.23% | 0.23% | 0.23% | Q2 2020 | Q2 2020 | 1 |
EXEL | EXELIXIS INC | 1 | 1 | 0.23% | 0.23% | 0.23% | Q2 2018 | Q2 2018 | 1 |
ICPT | INTERCEPT PHARMACEUTIC... | 1 | 1 | 0.23% | 0.23% | 0.23% | Q1 2019 | Q1 2019 | 1 |
ESPR | ESPERION THERAPEUTICS ... | 1 | 1 | 0.23% | 0.23% | 0.23% | Q3 2020 | Q3 2020 | 1 |
ITUB | ITAU UNIBANCO HLDG SA | 1 | 1 | 0.22% | 0.22% | 0.22% | Q2 2013 | Q2 2013 | 1 |
VLO | VALERO ENERGY CORP NEW | 1 | 1 | 0.22% | 0.22% | 0.22% | Q2 2013 | Q2 2013 | 1 |
WUBA | 58 COM INC | 1 | 1 | 0.22% | 0.22% | 0.22% | Q3 2017 | Q3 2017 | 1 |
MON | MONSANTO CO NEW | 1 | 1 | 0.21% | 0.21% | 0.21% | Q3 2014 | Q3 2014 | 1 |
SWAV | SHOCKWAVE MED INC | 1 | 1 | 0.20% | 0.20% | 0.20% | Q1 2019 | Q1 2019 | 1 |
ROC | ROCKWOOD HLDGS INC | 1 | 1 | 0.20% | 0.20% | 0.20% | Q2 2013 | Q2 2013 | 1 |
TME | TENCENT MUSIC ENTMT GROUP | 1 | 1 | 0.20% | 0.20% | 0.20% | Q1 2021 | Q1 2021 | 1 |
FB | FACEBOOK INC | 1 | 1 | 0.20% | 0.20% | 0.20% | Q2 2013 | Q2 2013 | 1 |
KORS | MICHAEL KORS HLDGS LTD | 1 | 1 | 0.20% | 0.20% | 0.20% | Q2 2013 | Q2 2013 | 1 |
AAVL | AVALANCHE BIOTECHNOLOG... | 1 | 1 | 0.19% | 0.19% | 0.19% | Q1 2015 | Q1 2015 | 1 |
MORF | MORPHIC HLDG INC | 1 | 1 | 0.18% | 0.18% | 0.18% | Q2 2023 | Q2 2023 | 1 |
FTDR | FRONTDOOR INC | 1 | 1 | 0.18% | 0.18% | 0.18% | Q2 2019 | Q2 2019 | 1 |
PMVP | PMV PHARMACEUTICALS INC | 1 | 1 | 0.17% | 0.17% | 0.17% | Q3 2020 | Q3 2020 | 1 |
SLB | SCHLUMBERGER LTD | 1 | 1 | 0.17% | 0.17% | 0.17% | Q2 2013 | Q2 2013 | 1 |
CNCE | CONCERT PHARMACEUTICAL... | 1 | 1 | 0.16% | 0.16% | 0.16% | Q3 2022 | Q3 2022 | 1 |
ITUB | ITAU UNIBANCO HLDG SA | 1 | 1 | 0.16% | 0.16% | 0.16% | Q2 2013 | Q2 2013 | 1 |
THIRD HARMONIC BIO INC | 1 | 1 | 0.16% | 0.16% | 0.16% | Q3 2022 | Q3 2022 | 1 | |
TSM | TAIWAN SEMICONDUCTOR M... | 1 | 1 | 0.16% | 0.16% | 0.16% | Q2 2020 | Q2 2020 | 1 |
LOGM | LOGMEIN INC | 1 | 1 | 0.15% | 0.15% | 0.15% | Q3 2018 | Q3 2018 | 1 |
FATE | FATE THERAPEUTICS INC | 1 | 1 | 0.15% | 0.15% | 0.15% | Q4 2019 | Q4 2019 | 1 |
CLDX | CELLDEX THERAPEUTICS I... | 1 | 1 | 0.15% | 0.15% | 0.15% | Q4 2020 | Q4 2020 | 1 |
YY | YY INC | 1 | 1 | 0.15% | 0.15% | 0.15% | Q2 2015 | Q2 2015 | 1 |
ARCO | ARCOS DORADOS HOLDINGS... | 1 | 1 | 0.15% | 0.15% | 0.15% | Q2 2013 | Q2 2013 | 1 |
JD | JD COM INC | 1 | 1 | 0.15% | 0.15% | 0.15% | Q2 2015 | Q2 2015 | 1 |
AMAG | AMAG PHARMACEUTICALS INC | 1 | 1 | 0.15% | 0.15% | 0.15% | Q3 2016 | Q3 2016 | 1 |
WFTIQ | WEATHERFORD INTL PLC | 1 | 1 | 0.14% | 0.14% | 0.14% | Q4 2014 | Q4 2014 | 1 |
FSLR | FIRST SOLAR INC | 1 | 1 | 0.14% | 0.14% | 0.14% | Q2 2013 | Q2 2013 | 1 |
CINCOR PHARMA INC | 1 | 1 | 0.14% | 0.14% | 0.14% | Q2 2022 | Q2 2022 | 1 | |
PHM | PULTE GROUP INC | 1 | 1 | 0.13% | 0.13% | 0.13% | Q3 2013 | Q3 2013 | 1 |
ITB | ISHARES | 1 | 1 | 0.13% | 0.13% | 0.13% | Q1 2015 | Q1 2015 | 1 |
OLAPLEX HLDGS INC | 1 | 1 | 0.12% | 0.12% | 0.12% | Q3 2021 | Q3 2021 | 1 | |
RDN | RADIAN GROUP INC | 1 | 1 | 0.12% | 0.12% | 0.12% | Q2 2014 | Q2 2014 | 1 |
ZTO | ZTO EXPRESS CAYMAN INC | 1 | 1 | 0.12% | 0.12% | 0.12% | Q4 2017 | Q4 2017 | 1 |
DTIL | PRECISION BIOSCIENCES INC | 1 | 1 | 0.11% | 0.11% | 0.11% | Q1 2019 | Q1 2019 | 1 |
PHAT | PHATHOM PHARMACEUTICAL... | 1 | 1 | 0.11% | 0.11% | 0.11% | Q4 2021 | Q4 2021 | 1 |
SPWR | SUNPOWER CORP | 1 | 1 | 0.11% | 0.11% | 0.11% | Q4 2013 | Q4 2013 | 1 |
STRUCTURE THERAPEUTICS... | 1 | 1 | 0.11% | 0.11% | 0.11% | Q1 2023 | Q1 2023 | 1 | |
BHG | BRIGHT HEALTH GROUP INC | 1 | 1 | 0.11% | 0.11% | 0.11% | Q2 2021 | Q2 2021 | 1 |
LUCID GROUP INC | 1 | 1 | 0.10% | 0.10% | 0.10% | Q2 2023 | Q2 2023 | 1 | |
ALLY | ALLY FINL INC | 1 | 1 | 0.10% | 0.10% | 0.10% | Q4 2014 | Q4 2014 | 1 |
ALDX | ALDEYRA THERAPEUTICS INC | 1 | 1 | 0.10% | 0.10% | 0.10% | Q2 2021 | Q2 2021 | 1 |
MINERVA NEUROSCIENCES INC | 1 | 1 | 0.10% | 0.10% | 0.10% | Q3 2022 | Q3 2022 | 1 | |
NTB | BANK OF NT BUTTERFIELD... | 1 | 1 | 0.10% | 0.10% | 0.10% | Q3 2016 | Q3 2016 | 1 |
CTRP | CTRIP COM INTL LTD | 1 | 1 | 0.09% | 0.09% | 0.09% | Q3 2016 | Q3 2016 | 1 |
ELAN | ELANCO ANIMAL HEALTH INC | 1 | 1 | 0.09% | 0.09% | 0.09% | Q3 2018 | Q3 2018 | 1 |
ISIS | ISIS PHARMACEUTICALS INC | 1 | 1 | 0.09% | 0.09% | 0.09% | Q3 2015 | Q3 2015 | 1 |
FLEX | FLEX LTD | 1 | 1 | 0.08% | 0.08% | 0.08% | Q3 2018 | Q3 2018 | 1 |
MNTA | MOMENTA PHARMACEUTICAL... | 1 | 1 | 0.08% | 0.08% | 0.08% | Q4 2018 | Q4 2018 | 1 |
PYPL | PAYPAL HLDGS INC | 1 | 1 | 0.08% | 0.08% | 0.08% | Q3 2023 | Q3 2023 | 1 |
VVUS | VIVUS INC | 1 | 1 | 0.08% | 0.08% | 0.08% | Q2 2013 | Q2 2013 | 1 |
CNAT | CONATUS PHARMACEUTICAL... | 1 | 1 | 0.08% | 0.08% | 0.08% | Q3 2018 | Q3 2018 | 1 |
CYRX | CRYOPORT INC | 1 | 1 | 0.08% | 0.08% | 0.08% | Q2 2020 | Q2 2020 | 1 |
PBYI | PUMA BIOTECHNOLOGY INC | 1 | 1 | 0.08% | 0.08% | 0.08% | Q4 2017 | Q4 2017 | 1 |
J106OPTLDIV | CBS OUTDOOR AMERS INC | 1 | 1 | 0.07% | 0.07% | 0.07% | Q3 2014 | Q3 2014 | 1 |
VVV | VALVOLINE INC | 1 | 1 | 0.07% | 0.07% | 0.07% | Q3 2016 | Q3 2016 | 1 |
RARE | ULTRAGENYX PHARMACEUTI... | 1 | 1 | 0.07% | 0.07% | 0.07% | Q3 2016 | Q3 2016 | 1 |
VNDA | VANDA PHARMACEUTICALS INC | 1 | 1 | 0.07% | 0.07% | 0.07% | Q4 2013 | Q4 2013 | 1 |
SUNEQ | SUNEDISON INC | 1 | 1 | 0.06% | 0.06% | 0.06% | Q3 2013 | Q3 2013 | 1 |
SHLS | SHOALS TECHNOLOGIES GR... | 1 | 1 | 0.06% | 0.06% | 0.06% | Q1 2021 | Q1 2021 | 1 |
NGM | NGM BIOPHARMACEUTICALS... | 1 | 1 | 0.06% | 0.06% | 0.06% | Q2 2019 | Q2 2019 | 1 |
LEN | LENNAR CORP | 1 | 1 | 0.06% | 0.06% | 0.06% | Q3 2013 | Q3 2013 | 1 |
TIGR | UP FINTECH HLDG LTD | 1 | 1 | 0.05% | 0.05% | 0.05% | Q1 2019 | Q1 2019 | 1 |
FCX | FREEPORT-MCMORAN INC | 1 | 1 | 0.05% | 0.05% | 0.05% | Q2 2017 | Q2 2017 | 1 |
HALO | HALOZYME THERAPEUTICS INC | 1 | 1 | 0.05% | 0.05% | 0.05% | Q4 2017 | Q4 2017 | 1 |
VNDA | VANDA PHARMACEUTICALS INC | 1 | 1 | 0.04% | 0.04% | 0.04% | Q4 2013 | Q4 2013 | 1 |
XP | XP INC | 1 | 1 | 0.04% | 0.04% | 0.04% | Q1 2022 | Q1 2022 | 1 |
MOLN | MOLECULAR PARTNERS AG | 1 | 1 | 0.04% | 0.04% | 0.04% | Q2 2021 | Q2 2021 | 1 |
GLPI | GAMING & LEISURE PPTYS... | 1 | 1 | 0.04% | 0.04% | 0.04% | Q1 2016 | Q1 2016 | 1 |
PAND | PANDION THERAPEUTICS INC | 1 | 1 | 0.04% | 0.04% | 0.04% | Q3 2020 | Q3 2020 | 1 |
BLCM | BELLICUM PHARMACEUTICA... | 1 | 1 | 0.04% | 0.04% | 0.04% | Q3 2017 | Q3 2017 | 1 |
IDRA | IDERA PHARMACEUTICALS INC | 1 | 1 | 0.04% | 0.04% | 0.04% | Q4 2020 | Q4 2020 | 1 |
HLI | HOULIHAN LOKEY INC | 1 | 1 | 0.04% | 0.04% | 0.04% | Q3 2015 | Q3 2015 | 1 |
KNSA | KINIKSA PHARMACEUTICAL... | 1 | 1 | 0.04% | 0.04% | 0.04% | Q2 2018 | Q2 2018 | 1 |
DOFSQ | DIAMOND OFFSHORE DRILL... | 1 | 1 | 0.04% | 0.04% | 0.04% | Q3 2016 | Q3 2016 | 1 |
JMEI | JUMEI INTL HLDG LTD | 1 | 1 | 0.03% | 0.03% | 0.03% | Q3 2015 | Q3 2015 | 1 |
SNNAQ | SIENNA BIOPHARMACEUTIC... | 1 | 1 | 0.03% | 0.03% | 0.03% | Q2 2018 | Q2 2018 | 1 |
CURIS INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q3 2023 | Q3 2023 | 1 | |
ARVN | ARVINAS INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q1 2023 | Q1 2023 | 1 |
NLNK | NEWLINK GENETICS CORP | 1 | 1 | 0.03% | 0.03% | 0.03% | Q3 2017 | Q3 2017 | 1 |
RYTM | RHYTHM PHARMACEUTICALS... | 1 | 1 | 0.02% | 0.02% | 0.02% | Q4 2017 | Q4 2017 | 1 |
NFLX | NETFLIX INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q3 2023 | Q3 2023 | 1 |
CLF | CLEVELAND-CLIFFS INC NEW | 1 | 1 | 0.02% | 0.02% | 0.02% | Q2 2022 | Q2 2022 | 1 |
UNG | UNITED STS NAT GAS FD LP | 1 | 1 | 0.02% | 0.02% | 0.02% | Q2 2022 | Q2 2022 | 1 |
RIVIAN AUTOMOTIVE INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q4 2021 | Q4 2021 | 1 | |
MBII | MARRONE BIO INNOVATION... | 1 | 1 | 0.02% | 0.02% | 0.02% | Q4 2021 | Q4 2021 | 1 |
BATH & BODY WORKS INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q2 2022 | Q2 2022 | 1 | |
HARPOON THERAPEUTICS INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q3 2023 | Q3 2023 | 1 | |
ADBE | ADOBE SYSTEMS INCORPOR... | 1 | 1 | 0.02% | 0.02% | 0.02% | Q3 2022 | Q3 2022 | 1 |
PEGA | PEGASYSTEMS INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2023 | Q3 2023 | 1 |
INTA | INTAPP INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2023 | Q3 2023 | 1 |
ATUS | ALTICE USA INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2021 | Q3 2021 | 1 |
LU | LUFAX HOLDING LTD | 1 | 1 | 0.01% | 0.01% | 0.01% | Q2 2021 | Q2 2021 | 1 |
STERLING CHECK CORP | 1 | 1 | 0.01% | 0.01% | 0.01% | Q2 2023 | Q2 2023 | 1 | |
GINKGO BIOWORKS HOLDIN... | 1 | 1 | 0.01% | 0.01% | 0.01% | Q1 2022 | Q1 2022 | 1 | |
DICE THERAPEUTICS INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q1 2023 | Q1 2023 | 1 | |
EQT | EQT CORP | 1 | 1 | 0.00% | 0.00% | 0.00% | Q3 2021 | Q3 2021 | 1 |
MANU | MANCHESTER UTD PLC NEW | 1 | 1 | 0.00% | 0.00% | 0.00% | Q1 2021 | Q1 2021 | 1 |
CONTRAFECT CORP | 1 | 1 | 0.00% | 0.00% | 0.00% | Q1 2023 | Q1 2023 | 1 | |
MICROVISION INC DEL | 1 | 1 | 0.00% | 0.00% | 0.00% | Q2 2013 | Q2 2013 | 1 | |
Download |
The securities at the top of the list , including AGENUS INC, IRONWOOD PHARMACEUTICALS INC, and ALNYLAM PHARMACEUTICALS INC, are the highest-conviction holdings of Artal Group S.A..
The conviction is calculated by counting the number of quarters a security has been reported by Artal Group S.A.. The higher the number, the higher the conviction and longer the holding period.
This page lists all the securities that Artal Group S.A. owns currently or has owned in the past.